0001104659-20-127404.txt : 20201119 0001104659-20-127404.hdr.sgml : 20201119 20201119171024 ACCESSION NUMBER: 0001104659-20-127404 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 43 CONFORMED PERIOD OF REPORT: 20200930 FILED AS OF DATE: 20201119 DATE AS OF CHANGE: 20201119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Montes Archimedes Acquisition Corp CENTRAL INDEX KEY: 0001819263 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-39597 FILM NUMBER: 201329550 BUSINESS ADDRESS: STREET 1: 724 OAK GROVE, SUITE 130 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 212-446-4600 MAIL ADDRESS: STREET 1: 724 OAK GROVE, SUITE 130 CITY: MENLO PARK STATE: CA ZIP: 94025 10-Q 1 tm2034947-1_10q.htm FORM 10-Q

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

  

FORM 10-Q

  

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2020

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                             to________________

 

MONTES ARCHIMEDES ACQUISITION CORP.

(Exact name of registrant as specified in its charter)

 

Delaware   001-39597   85-1830874

(State or other jurisdiction of

incorporation or organization)

 

  (Commission File Number)   (I.R.S. Employer
Identification Number)

 

724 Oak Grove Suite 130

Menlo Park, CA

  94025
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (650) 384-6558

 

Not Applicable

(Former name or former address, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class  

Trading

Symbol(s)

 

Name of each exchange

on which registered

Units, each consisting of one share of Class A common stock, $0.0001 par value, and one-half of one warrant   MAACU   The NASDAQ Stock Market LLC
         
Shares of Class A common stock included as part of the units   MAAC   The NASDAQ Stock Market LLC
         
Warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50  
MAACW
  The NASDAQ Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes  ¨  No   x

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   Yes  x  No  ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ¨ Accelerated filer ¨
Non-accelerated filer x Smaller reporting company x
Emerging growth company x    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ¨

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   Yes  x    No  ¨

 

As of November 19, 2020, 41,071,823 Class A common stock, par value $0.0001 per share, and 11,500,000 Class B common stock, par value $0.0001 per share, were issued and outstanding, respectively.

 

 

 

 

 

 

MONTES ARCHIMEDES ACQUISITION CORP.

Form 10-Q

For the Quarter Ended September 30, 2020

Table of Contents

 

    Page
PART I. FINANCIAL INFORMATION  
     
Item 1. Financial Statements (Unaudited) 1
     
  Unaudited Condensed Balance Sheet as of September 30, 2020 1
     
  Unaudited Condensed Statement of Operations for the period from July 6, 2020 (inception) through September 30, 2020 2
     
  Unaudited Condensed Statement of Changes in Stockholders’ Deficit for the period from July 6, 2020 (inception) through September 30, 2020 3
     
  Unaudited Condensed Statement of Cash Flows for the period from July 6, 2020 (inception) through September 30, 2020 4
     
  Notes to Unaudited Condensed Financial Statements 5
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 15
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 18
     
Item 4. Controls and Procedures 18
   
PART II. OTHER INFORMATION  
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities 18
     
Item 6. Exhibits 19

 

 

 

 

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements (Unaudited)

 

MONTES ARCHIMEDES ACQUISITION CORP.

UNAUDITED CONDENSED BALANCE SHEET

SEPTEMBER 30, 2020 

 

Assets:     
Current assets:     
Cash  $18,130 
Prepaid expenses   16,000 
Total current assets   34,130 
Deferred offering costs associated with intial public offering   498,285 
Total Assets  $532,415 
      
Liabilities and Stockholders' Deficit:     
Current liabilities:     
Accounts payable  $32,817 
Accrued expenses   298,046 
Franchise tax payable   47,173 
Note payable - related party   200,000 
Total current liabilities   578,036 
      
Commitments and Contingencies     
      
Stockholders' Deficit:     
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding   - 
Class A common stock, $0.0001 par value; 400,000,000 shares authorized; none issued and outstanding   - 
Class B common stock, $0.0001 par value; 40,000,000 shares authorized; 11,500,000 shares issued and outstanding (1)(2)   1,150 
Additional paid-in capital   23,850 
Accumulated deficit   (70,621)
Total stockholders' Deficit   (45,621)
Total Liabilities and Stockholders' Deficit  $532,415 

 

(1) This number includes up to 1,500,000 shares of Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On November 12, 2020, the underwriters partially exercised the over-allotment option to purchase as additional 1,071,823 Units; thus, only 1,285,637 Class B ordinary shares remain subject to forfeiture (see Note 4).

 

(2) On October 6, 2020, the Sponsor surrendered 2,875,000 shares of Class B common stock to the Company for no consideration, resulting in a decrease of the founder shares from 14,375,000 shares to 11,500,000 shares.  All shares and associated amounts have been retroactively restated to reflect the share surrender (see Note 4).

 

The accompanying notes are an integral part of these unaudited condensed financial statements. 

 

1

 

 

MONTES ARCHIMEDES ACQUISITION CORP.

UNAUDITED CONDENSED STATEMENT OF OPERATIONS

 

FOR THE PERIOD FROM JULY 6, 2020 (INCEPTION) THROUGH SEPTEMBER 30, 2020

 

General and administrative expenses  $23,448 
Franchise tax expense   47,173 
Net loss  $(70,621)
      
Weighted average shares outstanding, basic and diluted (1)(2)   10,214,363 
      
Basic and diluted net loss per share  $(0.01)

 

(1) This number excludes an aggregate of up to 1,500,000 Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On November 12, 2020, the underwriters partially exercised the over-allotment option to purchase as additional 1,071,823 Units; thus, only 1,285,637 Class B ordinary shares remain subject to forfeiture (see Note 4).
 
(2) On October 6, 2020, the Sponsor surrendered 2,875,000 shares of Class B common stock to the Company for no consideration, resulting in a decrease of the founder shares from 14,375,000 shares to 11,500,000 shares.  All shares and associated amounts have been retroactively restated to reflect the share surrender (see Note 4).

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 2 

 

 

MONTES ARCHIMEDES ACQUISITION CORP.

UNAUDITED CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS’ DEFICIT

 

FOR THE PERIOD FROM JULY 6, 2020 (INCEPTION) THROUGH SEPTEMBER 30, 2020

 

   Common Stock   Additional        Total 
   Class A   Class B   Paid-In   Accumulated   Stockholders' 
   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
Balance - July 6, 2020 (inception)          -   $       -    -   $-   $-   $-   $- 
Issuance of Class B common stock to Sponsor (1)(2)   -    -    11,500,000    1,150    23,850    -    25,000 
Net loss (unaudited)   -    -    -    -    -    (70,621)   (70,621)
Balance - September 30, 2020 (unaudited)   -   $-    11,500,000   $1,150   $23,850   $(70,621)  $(45,621)

 

(1) This number includes up to 1,500,000 shares of Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On November 12, 2020, the underwriters partially exercised the over-allotment option to purchase as additional 1,071,823 Units; thus, only 1,285,637 Class B ordinary shares remain subject to forfeiture (see Note 4).

 

(2) On October 6, 2020, the Sponsor surrendered 2,875,000 shares of Class B common stock to the Company for no consideration, resulting in a decrease of the founder shares from 14,375,000 shares to 11,500,000 shares.  All shares and associated amounts have been retroactively restated to reflect the share surrender (see Note 4).

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 3 

 

 

MONTES ARCHIMEDES ACQUISITION CORP.

UNAUDITED CONDENSED STATEMENT OF CASH FLOWS

 

FOR THE PERIOD FROM JULY 6, 2020 (INCEPTION) THROUGH SEPTEMBER 30, 2020

 

Cash Flows from Operating Activities:    
Net loss  $(70,621)
Changes in operating assets and liabilities:     
Accounts payable   17,367 
Accrued expenses   6,046 
Franchise tax payable   47,173 
Net cash used in operating activities   (35)
      
Cash Flows from Financing Activities:     
Proceeds from note payable to related party   200,000 
Deferred offering costs paid   (181,835)
Net cash provided by financing activities   18,165 
      
Net increase in cash   18,130 
      
Cash - beginning of the period   - 
Cash - end of the period  $18,130 
      
Supplemental disclosure of noncash activities:     
Offering costs paid by Sponsor in exchange for issuance of Class B common stock  $9,000 
Prepaid expenses paid by Sponsor in exchange for issuance of Class B common stock  $16,000 
Deferred offering costs included in accrued expenses  $292,000 
Deferred offering costs included in accounts payable  $15,450 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 4 

 

 

MONTES ARCHIMEDES ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

Note 1—Description of Organization, Business Operations and Basis of Presentation

 

Montes Archimedes Acquisition Corp. (the "Company") was incorporated in Delaware on July 6, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the "Business Combination"). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.

 

As of September 30, 2020, the Company had not commenced any operations. All activity for the period from July 6, 2020 (inception) through September 30, 2020 relates to the Company's formation and the preparation for the initial public offering (the “Initial Public Offering”) described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.

 

The Company's sponsor is Patient Square Capital LLC (the "Sponsor"). The registration statement for the Company’s Initial Public Offering was declared effective on October 6, 2020. On October 9, 2020, the Company consummated its Initial Public Offering of 40,000,000 units (the “Units”) at $10.00 per Unit, generating gross proceeds of $400.0 million, and incurring offering costs of approximately $22.1 million (net of reimbursement of offering costs of $520,000 from the underwriters), inclusive of $14.0 million in deferred underwriting commissions (Note 5). The underwriters exercised the over-allotment option in full and on November 12, 2020 purchased an additional 1,071,823 Units (the “Over-Allotment Units”), generating gross proceeds of approximately $10.7 million, and incurred additional offering costs of approximately $576,000 in underwriting fees (net of reimbursement of offering costs of approximately $14,000 from the underwriters and inclusive of approximately $375,000 in deferred underwriting fees) (the “Over-Allotment”).

 

Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 10,000,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant to the Sponsor, generating proceeds of $10.0 million (Note 4). Simultaneously with the closing of the Over-allotment on November 12, 2020, the Company consummated the second closing of the Private Placement, resulting in the purchase of an aggregate of an additional 214,365 Private Placement Warrants by the Sponsor, generating gross proceeds to the Company of approximately $214,000. 

 

Upon the closing of the Initial Public Offering, the Over-Allotment, and the Private Placement, approximately $410.7 million ($10.00 per Unit) of the net proceeds of the sale of the Units in the Initial Public Offering and of the Private Placement Warrants in the Private Placement were placed in a trust account ("Trust Account") located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in U.S. "government securities," within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act, which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.

 

The Company's management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete an initial Business Combination with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account). However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended (the "Investment Company Act").

 

5

 

 

MONTES ARCHIMEDES ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

The Company will provide holders (the "Public Stockholders") of the Company's outstanding shares of Class A common stock sold in the Initial Public Offering (the "Public Shares") with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the Trust Account (initially anticipated to be $10.00 per Public Share), calculated as of two business days prior to the initial Business Combination, including interest earned on the funds held in the trust account and not previously released to the Company to pay the Company's taxes, net of taxes payable. The per-share amount to be distributed to Public Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). The Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination. The Company will not redeem the Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001. If a stockholder vote is not required by applicable law or stock exchange rule and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its amended and restated certificate of incorporation (the "Certificate of Incorporation"), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission ("SEC") and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by applicable law or stock exchange rule, or the Company decides to obtain stockholder approval for business or reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Stockholder may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction. If the Company seeks stockholder approval in connection with a Business Combination, the initial stockholders (as defined below) agreed to vote any Founder Shares (as defined below in Note 4) and any Public Shares held by them in favor of a Business Combination. In addition, the initial stockholders agreed to waive their redemption rights with respect to any Founder Shares and any Public Shares held by them in connection with the completion of a Business Combination.

 

The Certificate of Incorporation will provide that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a "group" (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act")), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company. The Sponsor and the Company's officers and directors (the "initial stockholders") agreed, pursuant to a letter agreement with the Company, that they will not propose any amendment to the Certificate of Incorporation (A) to modify the substance or timing of the Company's obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (B) with respect to any other provision relating to stockholders' rights or pre-initial Business Combination activity, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable) divided by the number of then outstanding Public Shares.

 

If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or October 9, 2022, (as such period may be extended pursuant to the Certificate of Incorporation, the "Combination Period"), the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of the then outstanding Public Shares, which redemption will completely extinguish Public Stockholders' rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law; and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the board of directors, liquidate and dissolve, subject in each case, to the Company's obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

 

6

 

 

MONTES ARCHIMEDES ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

The initial stockholders agreed to waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares held by them if the Company fails to complete a Business Combination within the Combination Period. However, if the initial stockholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to the deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only, or less than, $10.00. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company's independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement (a "Target"), reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to the monies held in the Trust Account nor will it apply to any claims under the Company's indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the "Securities Act"). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, then the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

 

Liquidity and Capital Resources

 

As of September 30, 2020, the Company had approximately $18,000 cash and a working capital deficit of approximately $497,000.

 

Prior to September 30, 2020, the Company’s liquidity needs were satisfied through a payment of $25,000 from the Sponsor to cover certain expenses on behalf of the Company in exchange for the issuance of the Founder Shares (as defined below), the loan under the Note from the Sponsor of $200,000 (see Note 4) to the Company. Subsequent to September 30, 2020, the liquidity needs had been satisfied through the net proceeds from the consummation of the Private Placement not held in the Trust Account. The Company fully repaid the Note on October 9, 2020. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company's officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 4). To date, there were no amounts outstanding under any Working Capital Loans.

  

Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.

 

Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that the specific impact is not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis of Presentation

 

The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the period presented. Operating results for the period from May 19, 2020 (inception) through September 30, 2020 are not necessarily indicative of the results that may be expected through December 31, 2020.

 

The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 8-K and the final prospectus filed by the Company with the SEC on October 16, 2020 and October 9, 2020, respectively.

 

7

 

 

MONTES ARCHIMEDES ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

Emerging Growth Company

 

The Company is an "emerging growth company," as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the "JOBS Act"), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

 

This may make comparison of the Company's financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

Note 2—Summary of Significant Accounting Policies

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. At September 30, 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

 

Cash and Cash Equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of September 30, 2020.

  

Financial Instruments

 

The fair value of the Company's assets and liabilities, which qualify as financial instruments under FASB ASC 820, "Fair Value Measurement" approximates the carrying amounts represented in the balance sheet.

 

Use of Estimates

 

The preparation of the financial statements in conformity with U.S. GAAP requires the Company's management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

 

8

 

 

MONTES ARCHIMEDES ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

Deferred Offering Costs Associated with the Initial Public Offering

 

Deferred offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering and that were charged to stockholders’ equity upon the completion of the Initial Public Offering in October 2020.

 

Net Loss Per Common Share

      

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, "Earnings Per Share." Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period excluding common stock subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 1,500,000 shares of common stock that are subject to forfeiture if the over-allotment option is not exercised by the underwriters (Note 4). At September 30, 2020, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into shares of common stock and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented.

 

Income Taxes

 

The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, "Income Taxes." Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. Deferred tax assets were deemed immaterial as of September 30, 2020.

 

FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2020. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of September 30, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

 

Recent Accounting Standards

 

The Company's management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying financial statements.

 

Note 3—Initial Public Offering

 

On October 9, 2020, the Company consummated its Initial Public Offering of 40,000,000 Units at $10.00 per Unit, generating gross proceeds of $400.0 million, and incurring offering costs of approximately $22.1 million (net of reimbursement of offering costs of $520,000 from the underwriters), inclusive of $14.0 million in deferred underwriting commissions. The Underwriters exercised the over-allotment option in full and on November 12, 2020 purchased an additional 1,071,823 Over-Allotment Units, generating gross proceeds of approximately $10.7 million, and incurred additional offering costs of approximately $576,000 in underwriting fees (net of reimbursement of offering costs of approximately $14,000 from the underwriters and inclusive of approximately $375,000 in deferred underwriting fees).

 

Each Unit consists of one share of Class A common stock, and one-half of one redeemable warrant (each, a "Public Warrant"). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 6).

 

9

 

 

MONTES ARCHIMEDES ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

Note 4—Related Party Transactions

 

Founder Shares

 

On July 23, 2020, an affiliate of the Sponsor paid an aggregate of $25,000 for certain expenses on behalf of the Company in exchange for issuance of 14,375,000 shares of the Company's Class B common stock, par value $0.0001 per share (the "Founder Shares"), with such shares subsequently transferred to the Sponsor. On October 6, 2020, the Sponsor surrendered 2,875,000 shares of Class B common stock to the Company for no consideration, resulting in a decrease of the Founder Shares from 14,375,000 shares to 11,500,000 shares. All shares and associated amounts have been retroactively restated to reflect the share surrender. The initial stockholders agreed to forfeit up to 1,500,000 Founder Shares to the extent that the over-allotment option is not exercised in full by the underwriters, so that the Founder Shares will represent 20.0% of the Company's issued and outstanding shares of common stock after the Initial Public Offering. The underwriters exercised their over-allotment option on November 12, 2020; thus, only 1,285,637 shares of Class B common stock remain subject to forfeiture.

 

The Initial Stockholders agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination or (B) subsequent to the initial Business Combination, (x) if the last reported sale price of Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the stockholders having the right to exchange their common stock for cash, securities or other property.

 

Private Placement Warrants

 

Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 10,000,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant to the Sponsor, generating proceeds of $10.0 million. Simultaneously with the closing of the Over-allotment on November 12, 2020, the Company consummated the second closing of the Private Placement, resulting in the purchase of an aggregate of an additional 214,365 Private Placement Warrants by the Sponsor, generating gross proceeds to the Company of approximately $214,000. 

 

Each whole Private Placement Warrant is exercisable for one whole share of Class A common stock at a price of $11.50 per share, subject to adjustment. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable for cash (except as described below) and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees.

 

The Sponsor agreed, subject to limited exceptions, not to transfer, assign or sell the Private Placement Warrants until 30 days after the completion of the initial Business Combination.

 

Related Party Loans

 

On July 23, 2020, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the "Note"). This loan was non-interest bearing and payable upon the completion of the Initial Public Offering. As of September 30, 2020, the Company borrowed $200,000 under the Note. The Note was fully repaid on October 9, 2020.

 

In addition, in order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company's officers and directors may, but are not obligated to, loan the Company funds as may be required ("Working Capital Loans"). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans could be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender's discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. To date, the Company had no borrowings under the Working Capital Loans.

 

10

 

 

MONTES ARCHIMEDES ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

Administrative Services Agreement

 

The Company entered into an agreement that will provide that, commencing on October 7, 2020 through the earlier of consummation of the initial Business Combination and the liquidation, the Company will pay an affiliate of the Sponsor $10,000 per month for office space and administrative support services.

 

Note 5—Commitments & Contingencies

 

Registration Rights

 

The holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) are entitled to registration rights pursuant to the registration rights agreement. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain "piggy-back" registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Underwriting Agreement

 

The underwriters were entitled to an underwriting discount of $0.20 per unit, or $8.0 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or $14.0 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. The underwriters agreed to make a payment to the Company in an amount of 0.13% of the gross proceeds of the Initial Public Offering, or $520,000, to reimburse certain of offering expenses. The Company received such reimbursement on October 27, 2020.

 

Upon closing of the Over-allotment on November 12, 2020, the underwriters received approximately $214,000 in fees paid upfront and eligible for an additional deferred underwriting commissions of approximately $375,000. In addition, the underwriters agreed to make an addition payment to the Company in an amount of 0.13% of the gross proceeds of the Over-allotment, or approximately $14,000, to reimburse certain of offering expenses.

 

Note 6—Stockholders’ Equity

 

Class A Common Stock—The Company is authorized to issue 400,000,000 shares of Class A common stock with a par value of $0.0001 per share. As of September 30, 2020, there were no shares of Class A common stock issued or outstanding. 

 

Class B Common Stock—The Company is authorized to issue 40,000,000 shares of Class B common stock with a par value of $0.0001 per share. On July 23, 2020, an affiliate of the Sponsor paid an aggregate of $25,000 for certain expenses on behalf of the Company in exchange for issuance of 14,375,000 shares of Class B common stock, with such shares subsequently transferred to the Sponsor. On October 6, 2020, the Sponsor surrendered 2,875,000 shares of Class B common stock to the Company for no consideration, resulting in a decrease of the outstanding Class B common stock from 14,375,000 shares to 11,500,000 shares. All shares and associated amounts have been retroactively restated to reflect the share surrender. Of these, an aggregate of up to 1,500,000 shares of Class B common stock that are subject to forfeiture to the Company by the initial stockholders for no consideration to the extent that the underwriters' over- allotment option is not exercised in full or in part, so that the number of Founder Shares will equal 20% of the Company's issued and outstanding shares of common stock after the Initial Public Offering. The underwriters exercised their over-allotment option on November 12, 2020; thus, only 1,285,637 shares of Class B common stock remain subject to forfeiture.

 

11

 

 

MONTES ARCHIMEDES ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

Stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. Holders of our Class A common stock and holders of our Class B common stock will vote together as a single class on all matters submitted to a vote of our stockholders except as required by law.

 

The Class B common stock will automatically convert into Class A common stock on the first business day following the completion of the initial Business Combination at a ratio such that the number of shares of Class A common stock issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of (i) the total number of shares of Class A common stock issued and outstanding upon completion of the Initial Public Offering, plus (ii) the sum of (a) the total number of shares of Class A common stock issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the completion of the initial Business Combination, excluding any shares of Class A common stock or equity-linked securities exercisable for or convertible into shares of Class A common stock issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor upon conversion of Working Capital Loans, minus (b) the number of Public Shares redeemed by Public Stockholders in connection with the initial Business Combination. In no event will the shares of Class B common stock convert into shares of Class A common stock at a rate of less than one to one.

 

Preferred Stock—The Company is authorized to issue 1,000,000 shares of preferred stock, par value $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company's board of directors. As of September 30, 2020, there were no shares of preferred stock issued or outstanding.

 

Warrants—Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or holders are permitted to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement as a result of (i) the Company's failure to have an effective registration statement by the 60th business day after the closing of the initial Business Combination or (ii) a notice of redemption described below under "Redemption of warrants when the price per Class A common stock equals or exceeds $10.00"). If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

 

The Company is not registering the shares of Class A common stock issuable upon exercise of the warrants at this time. However, the Company has agreed that as soon as practicable, but in no event later than twenty business days after the closing of the initial Business Combination, the Company will use its commercially reasonable efforts to file with the SEC and have an effective registration statement covering the shares of Class A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed. If a registration statement covering the Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a "cashless basis" in accordance with Section 3(a)(9) of the Securities Act or another exemption.

 

The warrants will have an exercise price of $11.50 per share and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. If (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company and, (i) in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance, and (ii) to the extent that such issuance is made to the Sponsor or its affiliates, without taking into account the transfer of Founder Shares or Private Placement Warrants (including if such transfer is effectuated as a surrender to the Company and subsequent reissuance by the Company) by the Sponsor in connection with such issuance) (the "Newly Issued Price"), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the completion of the initial Business Combination (net of redemptions), and (z) the volume-weighted average trading price of Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company completes its initial Business Combination (such price, the "Market Value") is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices described under "Redemption of warrants when the price per Class A common stock equals or exceeds $18.00" and "Redemption of warrants when the price per Class A common stock equals or exceeds $10.00" will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively.

 

12

 

 

MONTES ARCHIMEDES ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

The Private Placement Warrants will be identical to the Public Warrants, except that the Private Placement Warrants (including the Class A common stock issuable upon exercise of the Private Placement Warrants) will not be transferable, assignable or salable until 30 days after the completion of the initial Business Combination and they will not be redeemable by the Company so long as they are held by the Sponsor or its permitted transferees.

 

Redemption of warrants when the price per share of our Class A common stock equals or exceeds $18.00:

 

Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):

 

  · in whole and not in part;

 

  · at a price of $0.01 per warrant;

 

  · upon a minimum of 30 days' prior written notice of redemption; and

 

  · if, and only if, the last reported sale price of Class A common stock for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders (the "Reference Value") equals or exceeds $18.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like).

 

However, in this case, the Company will not redeem the warrants unless an effective registration statement under the Securities Act covering the Class A common stock issuable upon exercise of the warrants is effective and a current prospectus relating to those shares of Class A common stock is available throughout the 30-day redemption period. Any such exercise would not be on a "cashless" basis and would require the exercising warrant holder to pay the exercise price for each warrant being exercised.

 

Redemption of warrants when the price per share of our Class A common stock equals or exceeds $10.00

 

Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):

 

  · in whole and not in part;

 

  · at $0.10 per warrant upon a minimum of 30 days' prior written notice of redemption, provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the "fair market value" of Class A common stock;

 

  · if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted for stock splits, stock dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like); and

  

  · if the Reference Value is less than $18.00 per share (as adjusted for stock splits, stock dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like), the Private Placement Warrants must also concurrently be called for redemption on the same terms (except as described herein with respect to a holder's ability to cashless exercise its warrants) as the outstanding Public Warrants, as described above.

 

13

 

 

MONTES ARCHIMEDES ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

The "fair market value" of Class A common stock shall mean the volume-weighted average price of Class A common stock for the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 shares of Class A common stock per warrant (subject to adjustment).

 

In no event will the Company be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company's assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

 

Note 7—Subsequent Events

 

The Company received the reimbursement of $520,000 from the underwriters for certain of offering expenses on October 27, 2020.

 

The Company evaluated subsequent events and transactions that occurred up to the date unaudited condensed financial statements were available to be issued. Based upon this review, the Company determined that, except as disclosed above and in Note 3 and 4, there have been no events that have occurred that would require adjustments to the disclosures in the unaudited condensed financial statements.

 

Management has evaluated subsequent events and transactions that occurred after the balance sheet date through the date the balance sheet was available for issuance. Based upon this review, except as noted above, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. 

 

14

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

References to the “Company,” “Montes Archimedes Acquisition Corp.,” “Montes,” “our,” “us” or “we” refer to Montes Archimedes Acquisition Corp. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited interim condensed financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

 

Cautionary Note Regarding Forward-Looking Statements

 

This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other SEC filings.

 

Overview

 

We are a blank check company incorporated in Delaware on July 6, 2020. We were formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the "Business Combination"). We are an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.

 

Our sponsor is Patient Square Capital LLC (the "Sponsor"). The registration statement for our Initial Public Offering was declared effective on October 6, 2020. On October 9, 2020, we consummated its Initial Public Offering of 40,000,000 units (the “Units”) at $10.00 per Unit, generating gross proceeds of $400.0 million, and incurring offering costs of approximately $22.1 million (net of reimbursement of offering costs of $520,000 from the underwriters), inclusive of $14.0 million in deferred underwriting commissions. The underwriters exercised the over-allotment option in full and on November 12, 2020 purchased an additional 1,071,823 Units (the “Over-Allotment Units”), generating gross proceeds of approximately $10.7 million, and incurred additional offering costs of approximately $576,000 in underwriting fees (net of reimbursement of offering costs of approximately $14,000 from the underwriters and inclusive of approximately $0.4 million in deferred underwriting fees) (the “Over-Allotment”).

 

Simultaneously with the closing of the Initial Public Offering, we consummated the private placement (“Private Placement”) of 10,000,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant to the Sponsor, generating proceeds of $10.0 million (Note 4). Simultaneously with the closing of the Over-allotment on November 12, 2020, we consummated the second closing of the Private Placement, resulting in the purchase of an aggregate of an additional 214,365 Private Placement Warrants by our Sponsor, generating gross proceeds to us of approximately $214,000.

 

Upon the closing of the Initial Public Offering, the Over-Allotment and the Private Placement$410.7 million ($10.00 per Unit) of the net proceeds of the sale of the Units in the Initial Public Offering and of the Private Placement Warrants in the Private Placement were placed in a trust account ("Trust Account") located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in U.S. "government securities," within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act, which invest only in direct U.S. government treasury obligations, as determined by us, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.

 

If we are unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or October 9, 2022, (as such period may be extended pursuant to the Certificate of Incorporation, the "Combination Period"), we will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the shares of Class A common stock sold in the Initial Public Offering (the "Public Shares"), at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to us to pay its taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of the then outstanding Public Shares, which redemption will completely extinguish Public Stockholders' rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law; and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the board of directors, liquidate and dissolve, subject in each case, to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

 

15

 

 

Liquidity and Capital Resources

 

As of September 30, 2020, we had approximately $18,000 cash and a working capital deficit of approximately $497,000.

 

Prior to September 30, 2020, our liquidity needs were satisfied through a payment of $25,000 from our Sponsor to cover certain expenses on behalf of us in exchange for the issuance of the Founder Shares (as defined below), the loan under the Note from our Sponsor of $200,000 (see Note 4) to us. Subsequent to September 30, 2020, the liquidity needs had been satisfied through the net proceeds from the consummation of the Private Placement not held in the Trust Account. We fully repaid the Note on October 9, 2020. In addition, in order to finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of our Sponsor, or certain of our officers and directors may, but are not obligated to, provide us Working Capital Loans. To date, there were no amounts outstanding under any Working Capital Loans.

  

Based on the foregoing, management believes that we will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, we will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.

 

Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that the specific impact is not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Results of Operations

 

Our entire activity since inception up to September 30, 2020 was in preparation for our formation and the Initial Public Offering. We will not be generating any operating revenues until the closing and completion of our initial Business Combination.

 

For the period from July 6, 2020 (inception) through September 30, 2020, we had net loss of approximately $70,600, which consisted of approximately $23,000 in general and administrative expenses and approximately $47,000 in franchise tax expense.

 

Contractual Obligations

 

Registration Rights

 

The holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) are entitled to registration rights pursuant to the registration rights agreement. The holders of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain "piggy-back" registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. We will bear the expenses incurred in connection with the filing of any such registration statements.

 

 16 

 

 

Underwriting Agreement

 

The underwriters were entitled to an underwriting discount of $0.20 per unit, or $8.0 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or $14.0 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that we complete a Business Combination, subject to the terms of the underwriting agreement. The underwriters agreed to make a payment to us in an amount of 0.13% of the gross proceeds of the Initial Public Offering, or $520,000, to reimburse certain of offering expenses. We received such reimbursement on October 27, 2020.

 

Upon closing of the Over-allotment on November 12, 2020, the underwriters received approximately $214,000 in fees paid upfront and eligible for an additional deferred underwriting commissions of approximately $375,000. In addition, the underwriters agreed to make an addition payment to us in an amount of 0.13% of the gross proceeds of the Over-allotment, or approximately $14,000, to reimburse certain of offering expenses. 

 

Critical Accounting Policies

 

Deferred Offering Costs Associated with the Initial Public Offering

 

Deferred offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering and that were charged to stockholders’ equity upon the completion of the Initial Public Offering in October 2020.

 

Net Loss Per Common Share

      

We comply with accounting and disclosure requirements of FASB ASC Topic 260, "Earnings Per Share." Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period excluding common stock subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 1,500,000 shares of common stock that are subject to forfeiture if the over-allotment option is not exercised by the underwriters (Note 4). At September 30, 2020, we did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into shares of common stock and then share in the earnings of our company. As a result, diluted loss per share is the same as basic loss per share for the period presented.

 

Off-Balance Sheet Arrangements

 

As of September 30, 2020, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.

 

JOBS Act

 

The Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” and under the JOBS Act are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, the financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

 

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our Initial Public Offering or until we are no longer an “emerging growth company,” whichever is earlier.

 

 17 

 

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item. As of September 30, 2020, we were not subject to any market or interest rate risk. The net proceeds of the Initial Public Offering, including amounts in the Trust Account, will be invested in U.S. government securities with a maturity of 185 days or less or in money market funds that meet certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended, that invest only in direct U.S. government treasury obligations. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk.

 

We have not engaged in any hedging activities since our inception and we do not expect to engage in any hedging activities with respect to the market risk to which we are exposed.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended September 30, 2020, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial officer has concluded that during the period covered by this report, our disclosure controls and procedures were effective.

 

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

Changes in Internal Control over Financial Reporting

 

There was no change in our internal control over financial reporting that occurred during the fiscal quarter ended September 30, 2020 covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

PART II - OTHER INFORMATION

  

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

On October 9, 2020, we consummated the Initial Public Offering of 40,000,000 Units. The Units sold in the Initial Public Offering were sold at an offering price of $10.00 per unit, generating total gross proceeds of $400,000,000. The Company granted the underwriters a 45-day option to purchase up to an additional 6,000,000 Units at the Initial Public Offering price to cover over-allotments, if any. Citigroup Global Markets Inc. and Jefferies LLC acted as the book-running managers. The securities in the offering were registered under the Securities Act on a registration statement on Form S-1 (No. 333-248802). The Securities and Exchange Commission declared the registration statement effective on October 6, 2020.

 

On November 10, the underwriters exercised the over-allotment option in part, and the closing of the issuance and sale of the additional 1,071,823 Units (the “Over-Allotment Option Units”) and the additional 214,365 Private Placement Warrants occurred on November 12, 2020, which resulted in total gross proceeds of $10,932,594.50 and net proceeds of $10,503,865.

 

Simultaneous with the consummation of the Initial Public Offering and the Over-allotment, we consummated the private placement of an aggregate of 10,000,000 warrants at a price of $1.00 per Private Placement Warrant, generating total proceed of $10,000,000. The issuance was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

 

 18 

 

 

The Private Placement Warrants are substantially similar to the warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants, if held by the Sponsor or its permitted transferees, they (i) may be exercised for cash or on a cashless basis, (ii) are not subject to being called for redemption under certain redemption scenarios and (iii) subject to certain limited exceptions, will be subject to transfer restrictions until 30 days following the consummation of the Company’s initial business combination. If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company under all redemption scenarios and exercisable by holders on the same basis as the Public Warrants. The Private Placement Warrants have been issued pursuant to, and are governed by the Warrant Agreement.

 

Of the gross proceeds received from the Initial Public Offering, the closing of the over-allotment option and the Private Placement Warrants, $413,200,094 was placed in the Trust Account.


We paid a total of $8,214,365 in underwriting discounts and commissions and approximately $129,000 for other offering costs related to the Initial Public Offering (net of reimbursement of offering costs of $533,934 from the underwriter). In addition, the underwriter agreed to defer $14,375,138 in underwriting discounts and commissions.

 

Item 6. Exhibits.

 

Exhibit

Number

  Description
31.1*   Certification of Chairman and Co-Chief Executive Officer (Principal Executive Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*   Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*   Certification of Chairman and Co-Chief Executive Officer (Principal Executive Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*   Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS   XBRL Instance Document
101.SCH   XBRL Taxonomy Extension Schema Document
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   XBRL Taxonomy Extension Label Linkbase Document
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document

 

  * These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

 

 19 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: November 19, 2020 MONTES ARCHIMEDES ACQUISITION CORP.
     
  By: /s/ James C. Momtazee
  Name: James C. Momtazee
  Title: Chief Executive Officer

 

 20 

 

EX-31.1 2 tm2034947d1_ex31-1.htm EXHIBIT 31.1

 

EXHIBIT 31.1

 

CERTIFICATION

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, James C. Momtazee, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2020 of Montes Archimedes Acquisition Corp.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b. [Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313];

 

  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

Date: November 19, 2020 By: /s/ James C. Momtazee
    James C. Momtazee
    Chief Executive Officer
    (Principal Executive Officer)

 

  

 

EX-31.2 3 tm2034947d1_ex31-2.htm EXHIBIT 31.2

 

EXHIBIT 31.2

 

CERTIFICATION

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Maria C. Walker, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2020 of Montes Archimedes Acquisition Corp.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b. [Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313];

 

  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

Date: November 19, 2020 By: /s/ Maria C. Walker
    Maria C. Walker
    Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

  

 

EX-32.1 4 tm2034947d1_ex32-1.htm EXHIBIT 32.1

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Montes Archimedes Acquisition Corp. (the “Company”) on Form 10-Q for the quarter ended September 30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, James C. Momtazee, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

  (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 19, 2020 /s/ James C. Momtazee
  Name: James C. Momtazee
  Title: Chief Executive Officer
    (Principal Executive Officer)

 

  

 

EX-32.2 5 tm2034947d1_ex32-2.htm EXHIBIT 32.2

 

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Montes Archimedes Acquisition Corp. (the “Company”) on Form 10-Q for the quarter ended September 30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Maria C. Walker, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

  (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 19, 2020 /s/ Maria C. Walker
  Name: Maria C. Walker
  Title: Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

  

 

EX-101.INS 6 maacu-20200930.xml XBRL INSTANCE DOCUMENT 0001819263 us-gaap:AdditionalPaidInCapitalMember 2020-07-06 2020-09-30 0001819263 maacu:FounderSharesMember maacu:AffiliateOfSponsorMember us-gaap:CommonClassBMember 2020-07-23 2020-07-23 0001819263 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-07-06 2020-09-30 0001819263 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-09-30 0001819263 us-gaap:RetainedEarningsMember 2020-09-30 0001819263 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001819263 us-gaap:RetainedEarningsMember 2020-07-05 0001819263 us-gaap:AdditionalPaidInCapitalMember 2020-07-05 0001819263 2020-07-05 0001819263 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-09-30 0001819263 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-07-05 0001819263 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-07-05 0001819263 srt:MaximumMember maacu:ClosingOfInitialBusinessCombinationMember 2020-09-30 0001819263 maacu:ClosingOfInitialBusinessCombinationMember us-gaap:CommonClassAMember 2020-09-30 0001819263 maacu:ClosingOfInitialBusinessCombinationMember maacu:PrivatePlacementWarrantsMember 2020-09-30 0001819263 maacu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceedsUsdTenMember 2020-09-30 0001819263 maacu:ClosingOfInitialBusinessCombinationMember 2020-09-30 0001819263 maacu:SponsorMember us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2020-11-12 2020-11-12 0001819263 maacu:UnsecuredPromissoryNoteMember maacu:RelatedPartyLoansMember maacu:SponsorMember 2020-09-30 0001819263 maacu:WorkingCapitalLoansMember maacu:RelatedPartyLoansMember 2020-09-30 0001819263 us-gaap:RetainedEarningsMember 2020-07-06 2020-09-30 0001819263 maacu:FounderSharesMember us-gaap:CommonClassBMember us-gaap:SubsequentEventMember 2020-10-06 0001819263 maacu:FounderSharesMember us-gaap:CommonClassBMember us-gaap:SubsequentEventMember 2020-10-05 0001819263 us-gaap:CommonClassBMember 2020-09-30 0001819263 us-gaap:CommonClassAMember 2020-09-30 0001819263 maacu:FounderSharesMember maacu:AffiliateOfSponsorMember us-gaap:CommonClassBMember 2020-07-23 0001819263 maacu:SponsorMember us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2020-11-12 0001819263 maacu:SponsorMember us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2020-10-09 0001819263 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2020-10-09 0001819263 maacu:PublicWarrantsMember us-gaap:CommonClassAMember 2020-09-30 0001819263 maacu:PublicWarrantsMember 2020-09-30 0001819263 maacu:SponsorMember us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2020-10-09 2020-10-09 0001819263 srt:MaximumMember maacu:FounderSharesMember us-gaap:SubsequentEventMember 2020-10-06 2020-10-06 0001819263 maacu:FounderSharesMember us-gaap:SubsequentEventMember 2020-10-06 2020-10-06 0001819263 us-gaap:CommonClassBMember us-gaap:SubsequentEventMember 2020-10-06 2020-10-06 0001819263 maacu:AdministrativeSupportAgreementMember maacu:AffiliateOfSponsorMember 2020-09-30 0001819263 us-gaap:SubsequentEventMember 2020-11-12 2020-11-12 0001819263 us-gaap:SubsequentEventMember 2020-10-27 2020-10-27 0001819263 us-gaap:SubsequentEventMember us-gaap:IPOMember 2020-10-09 2020-10-09 0001819263 us-gaap:SubsequentEventMember 2020-10-09 2020-10-09 0001819263 maacu:FounderSharesMember 2020-07-23 2020-07-23 0001819263 maacu:PublicWarrantsMember 2020-07-06 2020-09-30 0001819263 maacu:WorkingCapitalLoansMember maacu:RelatedPartyLoansMember 2020-07-23 0001819263 us-gaap:CommonClassBMember us-gaap:SubsequentEventMember 2020-11-12 0001819263 maacu:UnsecuredPromissoryNoteMember maacu:RelatedPartyLoansMember maacu:SponsorMember 2020-07-23 0001819263 us-gaap:CommonClassBMember 2020-07-06 2020-09-30 0001819263 us-gaap:SubsequentEventMember 2020-11-12 0001819263 us-gaap:SubsequentEventMember us-gaap:IPOMember 2020-10-09 0001819263 maacu:FounderSharesMember us-gaap:CommonClassBMember 2020-09-30 0001819263 maacu:PrivatePlacementWarrantsMember 2020-07-06 2020-09-30 0001819263 maacu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockIsLessThanUsdEighteenMember us-gaap:CommonClassAMember 2020-07-06 2020-09-30 0001819263 maacu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceedsUsdEighteenMember maacu:PrivatePlacementWarrantsMember 2020-07-06 2020-09-30 0001819263 srt:MaximumMember maacu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceedsUsdEighteenMember maacu:PublicWarrantsMember 2020-07-06 2020-09-30 0001819263 maacu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceedsUsdEighteenMember maacu:PublicWarrantsMember 2020-07-06 2020-09-30 0001819263 maacu:ClosingOfInitialBusinessCombinationMember 2020-07-06 2020-09-30 0001819263 us-gaap:IPOMember 2020-07-06 2020-09-30 0001819263 2020-09-30 0001819263 us-gaap:CommonClassAMember 2020-07-06 2020-09-30 0001819263 maacu:WarrantsIncludedAsPartOfUnitsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50Member 2020-07-06 2020-09-30 0001819263 maacu:UnitsEachConsistingOfOneShareOfClassCommonStock0.0001ParValueAndOneAndHalfOfOneWarrantMember 2020-07-06 2020-09-30 0001819263 us-gaap:CommonClassBMember 2020-11-19 0001819263 us-gaap:CommonClassAMember 2020-11-19 0001819263 2020-07-06 2020-09-30 maacu:item maacu:Vote iso4217:USD xbrli:shares xbrli:pure iso4217:USD xbrli:shares false --12-31 Q3 2020 2020-09-30 10-Q 0001819263 41071823 11500000 No true false Non-accelerated Filer Yes Montes Archimedes Acquisition Corp true true Units, each consisting of one share of Class A common stock, $0.0001 par value, and one-half of one warrant Warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 Shares of Class A common stock included as part of the units NASDAQ NASDAQ NASDAQ MAACU MAACW MAAC 47173 0.50 0.20 1.15 1.00 1.80 P30D P30D 18.00 10.00 P20D P30D P20D 0.01 0.10 1 0.200 0.20 0.35 15450 292000 14000000 14000000 375000 375000 14000000 375000 <div> <div> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Emerging Growth Company</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company is an "emerging growth company," as defined in Section&nbsp;2(a)&nbsp;of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the "JOBS Act"), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section&nbsp;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Further, Section&nbsp;102(b)(1)&nbsp;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">This may make comparison of the Company&#x2019;s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</font> </p><div /></div> </div> 16000 47173 47173 0.20 100000 300000 1500000 1500000 1500000 1500000 1500000 1071823 1071823 1071823 1071823 1071823 1285637 1285637 1285637 1285637 1285637 1500000 3 0.361 P60D 5000001 1.00 9000 0.80 0.60 10.00 25000 25000 25000 10.00 410700000 <div> <div> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Note&nbsp;3&#x2014;Initial Public Offering</font> </p> <p style="margin:0pt;text-align:center;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">On October&nbsp;9, 2020, the Company consummated its&nbsp;Initial Public Offering of 40,000,000 Units at $10.00 per Unit, generating gross proceeds of&nbsp;$400.0&nbsp;million, and incurring offering costs of approximately $22.1 million (net of reimbursement of offering costs of $520,000 from the underwriters), inclusive of $14.0&nbsp;million in deferred underwriting commissions. </font><font style="display:inline;color:#000000;background-color: #FFFFFF;">The Underwriters exercised the over-allotment option in full and on November 12, 2020 purchased an additional 1,071,823 Over-Allotment Units, generating gross proceeds of approximately $10.7 million, and incurred additional offering costs of approximately $576,000 in underwriting fees (net of reimbursement of offering costs of approximately $14,000 from the underwriters and inclusive of approximately $375,000 in deferred underwriting fees).&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Each Unit consists of one share of Class&nbsp;A common stock, and one-half of one redeemable warrant (each, a "Public Warrant"). Each whole Public Warrant entitles the holder to purchase one share of Class&nbsp;A common stock at a price of $11.50 per share, subject to adjustment (see Note&nbsp;6).</font> </p><div /></div> </div> 0.15 520000 520000 520000 14000 14000 0.0013 0.0013 520000 14000 10000 8000000 2875000 2875000 2875000 2875000 2875000 P2D P20D P30D P150D P30D P24M P10D P10D 12.00 True 214000 40000000 40000000 P30D P12M 1.00 497000 32817 298046 23850 1500000 532415 34130 <div> <div> <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Basis of Presentation</font> </p> <p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (&#x201C;GAAP&#x201D;) for financial information and pursuant to the rules&nbsp;and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the period presented. Operating results for the period from May&nbsp;19, 2020 (inception) through September&nbsp;30, 2020 are not necessarily indicative of the results that may be expected through December&nbsp;31, 2020.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form&nbsp;8&#8209;K and the final prospectus filed by the Company with the SEC on October&nbsp;16, 2020 and October&nbsp;9, 2020, respectively.</font> </p><div /></div> </div> 18130 <div> <div> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Cash and Cash Equivalents</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company considers all short-term investments with an original maturity of three&nbsp;months or less when purchased to be cash equivalents. The Company had no cash equivalents as of September&nbsp;30, 2020.</font> </p><div /></div> </div> 18130 18130 0 11.50 10.00 11.50 11.50 10000000 10000000 214365 214365 <div> <div> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <a name="_Hlk56494982"></a><font style="display:inline;">Note&nbsp;5&#x2014;Commitments&nbsp;&amp; Contingencies</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Registration Rights</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class&nbsp;A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) are entitled to registration rights pursuant to the registration rights agreement. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain "piggy-back" registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Underwriting Agreement</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The underwriters were entitled to an underwriting discount of $0.20 per unit, or $8.0&nbsp;million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or $14.0&nbsp;million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. The underwriters agreed to make a payment to the Company in an amount of 0.13% of the gross proceeds of the Initial Public Offering, or $520,000, to reimburse certain of offering expenses. The Company received such reimbursement on October&nbsp;27, 2020.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;background-color: #FFFFFF;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;color:#000000;">Upon closing of the Over-allotment on November 12, 2020, the underwriters received approximately $214,000 in fees paid upfront and eligible for an additional deferred underwriting commissions of approximately $375,000. In addition, the underwriters agreed to make an addition payment to the Company in an amount of 0.13% of the gross proceeds of the Over-allotment, or approximately $14,000, to reimburse certain of offering expenses</font><font style="display:inline;">.</font> </p><div /></div> </div> 0.0001 0.0001 0.0001 0.0001 0.0001 400000000 400000000 40000000 40000000 0 0 11500000 0 0 11500000 14375000 14375000 14375000 14375000 14375000 11500000 11500000 11500000 11500000 11500000 0 1150 <div> <div> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Concentration of Credit Risk</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. At September&nbsp;30, 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</font> </p><div /></div> </div> 250000 1.00 <div> <div> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Deferred Offering Costs Associated with the Initial Public Offering</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Deferred offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering and that were charged to stockholders&#x2019; equity upon the completion of the Initial Public Offering in October&nbsp;2020.</font> </p><div /></div> </div> 498285 -0.01 <div> <div> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Net Loss Per Common Share</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, "Earnings Per Share." Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period excluding common stock subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 1,500,000 shares of common stock that are subject to forfeiture if the over-allotment option is not exercised by the underwriters (Note&nbsp;4). At September&nbsp;30, 2020, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into shares of common stock and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented.</font> </p><div /></div> </div> <div> <div> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Financial Instruments</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under FASB ASC 820, "Fair Value Measurement" approximates the carrying amounts represented in the balance sheet.</font> </p><div /></div> </div> 23448 <div> <div> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Income Taxes</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, "Income Taxes." Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the&nbsp;years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. Deferred tax assets were deemed immaterial as of September&nbsp;30, 2020.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September&nbsp;30, 2020. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of September&nbsp;30, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</font> </p><div /></div> </div> 17367 6046 532415 578036 18165 -35 -70621 -70621 -70621 <div> <div> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Recent Accounting Standards</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company&#x2019;s management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying financial statements.</font> </p><div /></div> </div> 0 0 200000 200000 200000 <div> <div> <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Note&nbsp;1&#x2014;Description of Organization, Business Operations and Basis of Presentation</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Montes Archimedes Acquisition Corp. (the "Company") was incorporated in Delaware on July&nbsp;6, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the "Business Combination"). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">As of September&nbsp;30, 2020, the Company had not commenced any operations. All activity for the period from July&nbsp;6, 2020 (inception) through September&nbsp;30, 2020 relates to the Company&#x2019;s formation and the preparation for the initial public offering (the &#x201C;Initial Public Offering&#x201D;) described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering. The Company has selected December&nbsp;31 as its fiscal&nbsp;year end.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company&#x2019;s sponsor is Patient Square Capital LLC (the "Sponsor"). The registration statement for the Company&#x2019;s Initial Public Offering was declared effective on October&nbsp;6, 2020. On October&nbsp;9, 2020, the Company consummated its Initial Public Offering of 40,000,000 units (the &#x201C;Units&#x201D;) at $10.00 per Unit, generating gross proceeds of $400.0 million, and incurring offering costs of approximately $22.1 million (net of reimbursement of offering costs of $520,000 from the underwriters), inclusive of $14.0 million in deferred underwriting commissions (Note&nbsp;5). </font><font style="display:inline;color:#000000;background-color: #FFFFFF;">The underwriters exercised the over-allotment option in full and on November 12, 2020 purchased an additional 1,071,823 Units (the &#x201C;Over-Allotment Units&#x201D;), generating gross proceeds of approximately $10.7 million, and incurred additional offering costs of approximately $576,000 in underwriting fees (net of reimbursement of offering costs of approximately $14,000 from the underwriters and inclusive of approximately $375,000 in deferred underwriting fees) (the &#x201C;Over-Allotment&#x201D;).&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (&#x201C;Private Placement&#x201D;) of 10,000,000 warrants (each, a &#x201C;Private Placement Warrant&#x201D; and collectively, the &#x201C;Private Placement Warrants&#x201D;) at a price of $1.00 per Private Placement Warrant to the Sponsor, generating proceeds of $10.0&nbsp;million (Note&nbsp;4).&nbsp;</font><font style="display:inline;color:#000000;background-color: #FFFFFF;">Simultaneously with the closing of the Over-allotment on November 12, 2020, the Company consummated the second closing of the Private Placement, resulting in the purchase of an aggregate of&nbsp;an additional&nbsp;214,365 Private Placement Warrants&nbsp;by the Sponsor, generating gross proceeds to the Company of approximately $214,000.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Upon the closing of the Initial Public Offering, the Over-Allotment, and the Private Placement, approximately $410.7 million ($10.00 per Unit) of the net proceeds of the sale of the Units in the Initial Public Offering and of the Private Placement Warrants in the Private Placement were placed in a trust account ("Trust Account") located in the United States with Continental Stock Transfer &amp; Trust Company acting as trustee, and invested only in U.S. "government securities," within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in money market funds meeting certain conditions under Rule 2a&#8209;7 under the Investment Company Act, which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company&#x2019;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete an initial Business Combination with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account). However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended (the "Investment Company Act").</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company will provide holders (the "Public Stockholders") of the Company&#x2019;s outstanding shares of Class&nbsp;A common stock sold in the Initial Public Offering (the "Public Shares") with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i)&nbsp;in connection with a stockholder meeting called to approve the Business Combination or (ii)&nbsp;by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the Trust Account (initially anticipated to be $10.00 per Public Share), calculated as of two business&nbsp;days prior to the initial Business Combination, including interest earned on the funds held in the trust account and not previously released to the Company to pay the Company&#x2019;s taxes, net of taxes payable. The per-share amount to be distributed to Public Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note&nbsp;5). The Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination. The Company will not redeem the Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001. If a stockholder vote is not required by applicable law or stock exchange rule&nbsp;and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its amended and restated certificate of incorporation (the "Certificate of Incorporation"), conduct the redemptions pursuant to the tender offer rules&nbsp;of the U.S. Securities and Exchange Commission ("SEC") and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by applicable law or stock exchange rule, or the Company decides to obtain stockholder approval for business or reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules&nbsp;and not pursuant to the tender offer rules. Additionally, each Public Stockholder may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction. If the Company seeks stockholder approval in connection with a Business Combination, the initial stockholders (as defined below) agreed to vote any Founder Shares (as defined below in Note&nbsp;4) and any Public Shares held by them in favor of a Business Combination. In addition, the initial stockholders agreed to waive their redemption rights with respect to any Founder Shares and any Public Shares held by them in connection with the completion of a Business Combination.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Certificate of Incorporation will provide that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a "group" (as defined under Section&nbsp;13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act")), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company. The Sponsor and the Company&#x2019;s officers and directors (the "initial stockholders") agreed, pursuant to a letter agreement with the Company, that they will not propose any amendment to the Certificate of Incorporation (A)&nbsp;to modify the substance or timing of the Company&#x2019;s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (B)&nbsp;with respect to any other provision relating to stockholders&#x2019; rights or pre-initial Business Combination activity, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable) divided by the number of then outstanding Public Shares.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">If the Company is unable to complete a Business Combination within 24&nbsp;months from the closing of the Initial Public Offering, or October&nbsp;9, 2022, (as such period may be extended pursuant to the Certificate of Incorporation, the "Combination Period"), the Company will (i)&nbsp;cease all operations except for the purpose of winding up; (ii)&nbsp;as promptly as reasonably possible but not more than ten business&nbsp;days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of the then outstanding Public Shares, which redemption will completely extinguish Public Stockholders&#x2019; rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law; and (iii)&nbsp;as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the board of directors, liquidate and dissolve, subject in each case, to the Company&#x2019;s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The initial stockholders agreed to waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares held by them if the Company fails to complete a Business Combination within the Combination Period. However, if the initial stockholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to the deferred underwriting commission (see Note&nbsp;5) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only, or less than, $10.00. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company&#x2019;s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement (a "Target"), reduce the amount of funds in the Trust Account to below the lesser of (i)&nbsp;$10.00 per Public Share and (ii)&nbsp;the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to the monies held in the Trust Account nor will it apply to any claims under the Company&#x2019;s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the "Securities Act"). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, then the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Liquidity and Capital Resources</font> </p> <p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">As of September&nbsp;30, 2020, the Company had approximately $18,000 cash and a working capital deficit of approximately $497,000.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Prior to September&nbsp;30, 2020, the Company&#x2019;s liquidity needs were satisfied through a payment of $25,000 from the Sponsor to cover certain expenses on behalf of the Company in exchange for the issuance of the Founder Shares (as defined below), the loan under the Note&nbsp;from the Sponsor of $200,000 (see Note&nbsp;4) to the Company. Subsequent to September&nbsp;30, 2020, the liquidity needs had been satisfied through the net proceeds from the consummation of the Private Placement not held in the Trust Account. The Company fully repaid the Note&nbsp;on October&nbsp;9, 2020. In addition, in order to finance transaction costs in connection with a Business Combination,&nbsp;the Sponsor or an affiliate of the Sponsor, or certain of the Company&#x2019;s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note&nbsp;4). To date, there were no amounts outstanding under any Working Capital Loans.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one&nbsp;year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Management continues to evaluate the impact of the&nbsp;COVID&#8209;19&nbsp;pandemic and has concluded that the specific impact is not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Basis of Presentation</font> </p> <p style="margin:0pt;text-align:left;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (&#x201C;GAAP&#x201D;) for financial information and pursuant to the rules&nbsp;and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the period presented. Operating results for the period from May&nbsp;19, 2020 (inception) through September&nbsp;30, 2020 are not necessarily indicative of the results that may be expected through December&nbsp;31, 2020.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form&nbsp;8&#8209;K and the final prospectus filed by the Company with the SEC on October&nbsp;16, 2020 and October&nbsp;9, 2020, respectively.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Emerging Growth Company</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company is an "emerging growth company," as defined in Section&nbsp;2(a)&nbsp;of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the "JOBS Act"), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section&nbsp;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Further, Section&nbsp;102(b)(1)&nbsp;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">This may make comparison of the Company&#x2019;s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</font> </p><div /></div> </div> 181835 22100000 22100000 576000 576000 0.0001 0.0001 1000000 1000000 0 0 0 0 0 16000 10000000 400000000 400000000 10000000 10700000 10700000 214000 214000 200000 -70621 <div> <div> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Note&nbsp;4&#x2014;Related Party Transactions</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Founder Shares</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">On&nbsp;July&nbsp;23, 2020, an affiliate&nbsp;of the Sponsor paid an aggregate of $25,000 for certain expenses on behalf of the Company in exchange for issuance of 14,375,000 shares of the Company&#x2019;s Class&nbsp;B common stock, par value $0.0001 per share (the "Founder Shares"), with such shares subsequently transferred to the Sponsor. On October&nbsp;6, 2020, the Sponsor surrendered 2,875,000 shares of Class&nbsp;B common stock to the Company for no consideration, resulting in a decrease of the Founder Shares from 14,375,000 shares to 11,500,000 shares. All shares and associated amounts have been retroactively restated to reflect the share surrender. The initial stockholders agreed to forfeit up to 1,500,000 Founder Shares to the extent that the over-allotment option is not exercised in full by the underwriters, so that the Founder Shares will represent 20.0% of the Company&#x2019;s issued and outstanding shares of common stock after the Initial Public Offering. </font><font style="display:inline;color:#000000;background-color: #FFFFFF;">The underwriters exercised their over-allotment option on November 12, 2020;&nbsp;thus, only 1,285,637 shares of Class B common stock remain subject to forfeiture.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Initial Stockholders agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A)&nbsp;one&nbsp;year after the completion of the initial Business Combination or (B)&nbsp;subsequent to the initial Business Combination, (x)&nbsp;if the last reported sale price of Class&nbsp;A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading&nbsp;days within any 30&#8209;trading day period commencing at least 150&nbsp;days after the initial Business Combination, or (y)&nbsp;the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the stockholders having the right to exchange their common stock for cash, securities or other property.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Private Placement Warrants</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 10,000,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant to the Sponsor, generating proceeds of $10.0&nbsp;million.&nbsp;</font><font style="display:inline;color:#000000;background-color: #FFFFFF;">Simultaneously with the closing of the Over-allotment on November 12, 2020, the Company consummated the second closing of the Private Placement, resulting in the purchase of an aggregate of&nbsp;an additional&nbsp;214,365 Private Placement Warrants&nbsp;by the Sponsor, generating gross proceeds to the Company of approximately $214,000.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Each whole Private Placement Warrant is exercisable for one whole share of Class&nbsp;A common stock at a price of $11.50 per share, subject to adjustment. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable for cash (except as described below) and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Sponsor agreed, subject to limited exceptions, not to transfer, assign or sell the Private Placement Warrants until 30&nbsp;days after the completion of the initial Business Combination.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Related Party Loans</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">On&nbsp;July&nbsp;23, 2020, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the "Note"). This loan was non-interest bearing and payable upon the completion of the Initial Public Offering. As of September&nbsp;30, 2020, the Company borrowed $200,000 under the Note. The Note&nbsp;was fully repaid on October&nbsp;9, 2020.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">In addition, in order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#x2019;s officers and directors may, but are not obligated to, loan the Company funds as may be required ("Working Capital Loans"). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans could be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender&#x2019;s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. To date, the Company had no borrowings under the Working Capital Loans.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Administrative Services Agreement</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company entered into an agreement that will provide that, commencing on October&nbsp;7, 2020 through the earlier of consummation of the initial Business Combination and the liquidation, the Company will pay an affiliate of the Sponsor $10,000 per&nbsp;month for office space and administrative support services.</font> </p><div /></div> </div> -70621 0 9.20 10.00 18.00 9.20 18.00 10.00 10.00 1.00 0 0 11500000 <div> <div> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Note&nbsp;2&#x2014;Summary of Significant Accounting Policies</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Concentration of Credit Risk</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. At September&nbsp;30, 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Cash and Cash Equivalents</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company considers all short-term investments with an original maturity of three&nbsp;months or less when purchased to be cash equivalents. The Company had no cash equivalents as of September&nbsp;30, 2020.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Financial Instruments</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under FASB ASC 820, "Fair Value Measurement" approximates the carrying amounts represented in the balance sheet.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Use of Estimates</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The preparation of the financial statements in conformity with U.S.&nbsp;GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Deferred Offering Costs Associated with the Initial Public Offering</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Deferred offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering and that were charged to stockholders&#x2019; equity upon the completion of the Initial Public Offering in October&nbsp;2020.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Net Loss Per Common Share</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, "Earnings Per Share." Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period excluding common stock subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 1,500,000 shares of common stock that are subject to forfeiture if the over-allotment option is not exercised by the underwriters (Note&nbsp;4). At September&nbsp;30, 2020, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into shares of common stock and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Income Taxes</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, "Income Taxes." Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the&nbsp;years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. Deferred tax assets were deemed immaterial as of September&nbsp;30, 2020.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September&nbsp;30, 2020. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of September&nbsp;30, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Recent Accounting Standards</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company&#x2019;s management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying financial statements.</font> </p><div /></div> </div> 0 0 0 0 0 -45621 -45621 23850 -70621 0 0 1150 <div> <div> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Note&nbsp;6&#x2014;Stockholders&#x2019; Equity</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-weight:bold;font-style:italic;">Class&nbsp;A Common Stock</font><font style="display:inline;">&#x2014;The Company is authorized to issue 400,000,000 shares of Class&nbsp;A common stock with a par value of $0.0001 per share. As of September&nbsp;30, 2020, </font><font style="display:inline;font-family:Times;">there were no&nbsp;shares of Class&nbsp;A common stock issued or outstanding.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Class&nbsp;B Common Stock&#x2014;The Company is authorized to issue 40,000,000 shares of Class&nbsp;B common stock with a par value of $0.0001 per share. On July&nbsp;23, 2020, an affiliate of the Sponsor paid an aggregate of $25,000 for certain expenses on behalf of the Company in exchange for issuance of 14,375,000 shares of Class&nbsp;B common stock, with such shares subsequently transferred to the Sponsor. On October&nbsp;6, 2020, the Sponsor surrendered 2,875,000 shares of Class&nbsp;B common stock to the Company for no consideration, resulting in a decrease of the outstanding Class&nbsp;B common stock from 14,375,000 shares to 11,500,000 shares. All shares and associated amounts have been retroactively restated to reflect the share surrender. Of these, an aggregate of up to 1,500,000&nbsp;shares of Class&nbsp;B common stock that are subject to forfeiture to the Company by the initial stockholders for no consideration to the extent that the underwriters&#x2019; over-allotment option is not exercised in full or in part, so that the number of Founder Shares will equal 20% of the Company&#x2019;s issued and outstanding shares of common stock after the Initial Public Offering. </font><font style="display:inline;color:#000000;background-color: #FFFFFF;">The underwriters exercised their over-allotment option on November 12, 2020;&nbsp;thus, only 1,285,637 shares of Class B common stock remain subject to forfeiture.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. Holders of our Class&nbsp;A common stock and holders of our Class&nbsp;B common stock will vote together as a single class on all matters submitted to a vote of our stockholders except as required by law.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Class&nbsp;B common stock will automatically convert into Class&nbsp;A common stock on the first business day following the completion of the initial Business Combination at a ratio such that the number of shares of Class&nbsp;A common stock issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of (i)&nbsp;the total number of shares of Class&nbsp;A common stock issued and outstanding upon completion of the Initial Public Offering, plus (ii)&nbsp;the sum of (a)&nbsp;the total number of shares of Class&nbsp;A common stock issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the completion of the initial Business Combination, excluding any shares of Class&nbsp;A common stock or equity-linked securities exercisable for or convertible into shares of Class&nbsp;A common stock issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor upon conversion of Working Capital Loans, minus (b)&nbsp;the number of Public Shares redeemed by Public Stockholders in connection with the initial Business Combination. In no event will the shares of Class&nbsp;B common stock convert into shares of Class&nbsp;A common stock at a rate of less than one to one.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-weight:bold;font-style:italic;">Preferred Stock</font><font style="display:inline;">&#x2014;The Company is authorized to issue 1,000,000 shares of preferred stock, par value $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company&#x2019;s board of directors. As of September&nbsp;30, 2020, there were no&nbsp;shares of preferred stock issued or outstanding.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-weight:bold;font-style:italic;">Warrants</font><font style="display:inline;">&#x2014;Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a)&nbsp;30&nbsp;days after the completion of a Business Combination and (b)&nbsp;12&nbsp;months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the shares of Class&nbsp;A common stock issuable upon exercise of the warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or holders are permitted to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement as a result of (i)&nbsp;the Company&#x2019;s failure to have an effective registration statement by the 60th&nbsp;business day after the closing of the initial Business Combination or (ii)&nbsp;a notice of redemption described below under "Redemption of warrants when the price per Class&nbsp;A common stock equals or exceeds $10.00"). If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company is not registering the shares of Class&nbsp;A common stock issuable upon exercise of the warrants at this time. However, the Company has agreed that as soon as practicable, but in no event later than twenty business&nbsp;days after the closing of the initial Business Combination, the Company will use its commercially reasonable efforts to file with the SEC and have an effective registration statement covering the shares of Class&nbsp;A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class&nbsp;A common stock until the warrants expire or are redeemed. If a registration statement covering the Class&nbsp;A common stock issuable upon exercise of the warrants is not effective by the 60th&nbsp;business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a "cashless basis" in accordance with Section&nbsp;3(a)(9)&nbsp;of the Securities Act or another exemption.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The warrants will have an exercise price of $11.50 per share and will expire five&nbsp;years after the completion of a Business Combination or earlier upon redemption or liquidation. If (x)&nbsp;the Company issues additional shares of Class&nbsp;A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class&nbsp;A common stock (with such issue price or effective issue price to be determined in good faith by the Company and, (i)&nbsp;in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance, and (ii)&nbsp;to the extent that such issuance is made to the Sponsor or its affiliates, without taking into account the transfer of Founder Shares or Private Placement Warrants (including if such transfer is effectuated as a surrender to the Company and subsequent reissuance by the Company) by the Sponsor in connection with such issuance) (the "Newly Issued Price"), (y)&nbsp;the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the completion of the initial Business Combination (net of redemptions), and (z)&nbsp;the volume-weighted average trading price of Class&nbsp;A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company completes its initial Business Combination (such price, the "Market Value") is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices described under "Redemption of warrants when the price per Class&nbsp;A common stock equals or exceeds $18.00" and "Redemption of warrants when the price per Class&nbsp;A common stock equals or exceeds $10.00" will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Private Placement Warrants will be identical to the Public Warrants, except that the Private Placement Warrants (including the Class&nbsp;A common stock issuable upon exercise of the Private Placement Warrants) will not be transferable, assignable or salable until 30&nbsp;days after the completion of the initial Business Combination and they will not be redeemable by the Company so long as they are held by the Sponsor or its permitted transferees.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-style:italic;">Redemption of warrants when the price per share of our Class&nbsp;A common stock equals or exceeds $18.00:</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt 0pt 0pt 18pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="text-indent:0pt;margin-left:0pt; padding-right:11pt;"><font style="display:inline;font-family:Symbol;">&#xF0B7;</font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"></font><font style="display:inline;"></font><font style="display:inline;font-family:Times New Roman,Times,serif;">in whole and not in part;</font></font> </p> <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt 0pt 0pt 18pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="text-indent:0pt;margin-left:0pt; padding-right:11pt;"><font style="display:inline;font-family:Symbol;">&#xF0B7;</font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"></font><font style="display:inline;">at a price of $0.01 per warrant;</font></font> </p> <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt 0pt 0pt 18pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="text-indent:0pt;margin-left:0pt; padding-right:11pt;"><font style="display:inline;font-family:Symbol;">&#xF0B7;</font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"></font><font style="display:inline;"></font><font style="display:inline;font-family:Times New Roman,Times,serif;">upon a minimum of 30 days&#x2019; prior written notice of redemption; and</font></font> </p> <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt 0pt 0pt 36pt;text-indent: -18pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Symbol;">&#xF0B7;<font style="display:inline;font-family:Symbol;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 12pt 0pt 0pt;"></font></font><font style="display:inline;"></font><font style="display:inline;font-family:Times New Roman,Times,serif;">if, and only if, the last reported sale price of Class A common stock for any 20 trading days within a 30&#8209;trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders (the "Reference Value") equals or exceeds $18.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like).</font> </p> <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">However, in this case, the Company will not redeem the warrants unless an effective registration statement under the Securities Act covering the Class&nbsp;A common stock issuable upon exercise of the warrants is effective and a current prospectus relating to those shares of Class&nbsp;A common stock is available throughout the 30&#8209;day redemption period. Any such exercise would not be on a "cashless" basis and would require the exercising warrant holder to pay the exercise price for each warrant being exercised.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-style:italic;font-size: 10pt;"> <font style="display:inline;">Redemption of warrants when the price per share of our Class&nbsp;A common stock equals or exceeds $10.00</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt 0pt 0pt 18pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="text-indent:0pt;margin-left:0pt; padding-right:11pt;"><font style="display:inline;font-family:Symbol;">&#xF0B7;</font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"></font><font style="display:inline;"></font><font style="display:inline;font-family:Times New Roman,Times,serif;">in whole and not in part;</font></font> </p> <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt 0pt 0pt 36pt;text-indent: -18pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Symbol;">&#xF0B7;<font style="display:inline;font-family:Symbol;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 12pt 0pt 0pt;"></font></font><font style="display:inline;"></font><font style="display:inline;font-family:Times New Roman,Times,serif;">at $0.10 per warrant upon a minimum of 30 days&#x2019; prior written notice of redemption, provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the "fair market value" of Class A common stock;</font> </p> <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt 0pt 0pt 36pt;text-indent: -18pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Symbol;">&#xF0B7;<font style="display:inline;font-family:Symbol;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 12pt 0pt 0pt;"></font></font><font style="display:inline;"></font><font style="display:inline;font-family:Times New Roman,Times,serif;">if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted for stock splits, stock dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like); and</font> </p> <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt 0pt 0pt 36pt;text-indent: -18pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;font-family:Symbol;">&#xF0B7;<font style="display:inline;font-family:Symbol;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 12pt 0pt 0pt;"></font></font><font style="display:inline;"></font><font style="display:inline;font-family:Times New Roman,Times,serif;">if the Reference Value is less than $18.00 per share (as adjusted for stock splits, stock dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like), the Private Placement Warrants must also concurrently be called for redemption on the same terms (except as described herein with respect to a holder&#x2019;s ability to cashless exercise its warrants) as the outstanding Public Warrants, as described above.</font> </p> <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The "fair market value" of Class&nbsp;A common stock shall mean the volume-weighted average price of Class&nbsp;A common stock for the 10 trading&nbsp;days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 shares of Class&nbsp;A common stock per warrant (subject to adjustment).</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">In no event will the Company be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company&#x2019;s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.</font> </p><div /></div> </div> 11500000 14375000 14375000 25000 23850 1150 <div> <div> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Note&nbsp;7&#x2014;Subsequent Events</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company received the reimbursement of $520,000 from the underwriters for certain of offering expenses on October&nbsp;27, 2020.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The Company evaluated subsequent events and transactions that occurred up to the date unaudited condensed financial statements were available to be issued. Based upon this review, the Company determined that, except as disclosed above and in Note&nbsp;3 and 4, there have been no events that have occurred that would require adjustments to the disclosures in the unaudited condensed financial statements.</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">Management has evaluated subsequent events and transactions that occurred after the balance sheet date through the date the balance sheet was available for issuance. Based upon this review, except as noted above, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.</font> </p><div /></div> </div> 0 0 <div> <div> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 10pt;"> <font style="display:inline;">Use of Estimates</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">&nbsp;</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman,Times,serif;font-size: 10pt;"> <font style="display:inline;">The preparation of the financial statements in conformity with U.S.&nbsp;GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</font> </p><div /></div> </div> 10214363 On October 6, 2020, the Sponsor surrendered 2,875,000 shares of Class B common stock to the Company for no consideration, resulting in a decrease of the founder shares from 14,375,000 shares to 11,500,000 shares. All shares and associated amounts have been retroactively restated to reflect the share surrender (see Note 4). This number includes up to 1,500,000 shares of Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On November 12, 2020, the underwriters partially exercised the over-allotment option to purchase as additional 1,071,823 Units; thus, only 1,285,637 Class B ordinary shares remain subject to forfeiture (see Note 4). This number excludes an aggregate of up to 1,500,000 Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On November 12, 2020, the underwriters partially exercised the over-allotment option to purchase as additional 1,071,823 Units; thus, only 1,285,637 Class B ordinary shares remain subject to forfeiture (see Note 4). EX-101.SCH 7 maacu-20200930.xsd XBRL TAXONOMY EXTENSION SCHEMA 00100 - Statement - UNAUDITED CONDENSED BALANCE SHEET link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - UNAUDITED CONDENSED STATEMENT OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - UNAUDITED CONDENSED STATEMENT OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - UNAUDITED CONDENSED BALANCE SHEET (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00205 - Statement - UNAUDITED CONDENSED STATEMENT OF OPERATIONS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - UNAUDITED CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT link:presentationLink link:calculationLink link:definitionLink 00305 - Statement - UNAUDITED CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - Description of Organization, Business Operations and Basis of Presentation (Details) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - Initial Public Offering (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Related Party Transactions - Founder Shares (Details) link:presentationLink link:calculationLink link:definitionLink 40402 - Disclosure - Related Party Transactions - Private Placement Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 40403 - Disclosure - Related Party Transactions - Related Party Loans and Administrative Services Agreement (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Stockholders' Equity - Common Stock (Details) link:presentationLink link:calculationLink link:definitionLink 40603 - Disclosure - Stockholders' Equity - Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - Description of Organization, Business Operations and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - Initial Public Offering link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - Commitments & Contingencies link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 20202 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 40602 - Disclosure - Stockholders' Equity - Preferred Stock (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 maacu-20200930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 maacu-20200930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 maacu-20200930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 11 maacu-20200930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Document and Entity Information - shares
3 Months Ended
Sep. 30, 2020
Nov. 19, 2020
Document Type 10-Q  
Document Period End Date Sep. 30, 2020  
Entity Registrant Name Montes Archimedes Acquisition Corp  
Transition Report True  
Entity Current Reporting Status No  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company true  
Entity Central Index Key 0001819263  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2020  
Document Fiscal Period Focus Q3  
Amendment Flag false  
Units, each consisting of one share of Class A common stock, $0.0001 par value, and one-half of one warrant    
Title of 12(b) Security Units, each consisting of one share of Class A common stock, $0.0001 par value, and one-half of one warrant  
Trading Symbol MAACU  
Security Exchange Name NASDAQ  
Class A    
Title of 12(b) Security Shares of Class A common stock included as part of the units  
Trading Symbol MAAC  
Security Exchange Name NASDAQ  
Entity Common Stock, Shares Outstanding   41,071,823
Class B    
Entity Common Stock, Shares Outstanding   11,500,000
Warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50    
Title of 12(b) Security Warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50  
Trading Symbol MAACW  
Security Exchange Name NASDAQ  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.20.2
UNAUDITED CONDENSED BALANCE SHEET
Sep. 30, 2020
USD ($)
Current assets:  
Cash $ 18,130
Prepaid expenses 16,000
Total current assets 34,130
Deferred offering costs associated with initial public offering 498,285
Total Assets 532,415
Current liabilities:  
Accounts payable 32,817
Accrued expenses 298,046
Franchise tax payable 47,173
Note payable - related party 200,000
Total current liabilities 578,036
Commitments and Contingencies
Stockholders' Deficit:  
Preferred stock, $0.0001 par value 1,000,000 shares authorized none issued and outstanding 0
Additional paid-in capital 23,850
Accumulated deficit (70,621)
Total stockholders' Deficit (45,621)
Total Liabilities and Stockholders' Deficit 532,415
Class A  
Stockholders' Deficit:  
Common stock 0
Class B  
Stockholders' Deficit:  
Common stock $ 1,150 [1],[2]
[1] On October 6, 2020, the Sponsor surrendered 2,875,000 shares of Class B common stock to the Company for no consideration, resulting in a decrease of the founder shares from 14,375,000 shares to 11,500,000 shares. All shares and associated amounts have been retroactively restated to reflect the share surrender (see Note 4).
[2] This number includes up to 1,500,000 shares of Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On November 12, 2020, the underwriters partially exercised the over-allotment option to purchase as additional 1,071,823 Units; thus, only 1,285,637 Class B ordinary shares remain subject to forfeiture (see Note 4).
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.20.2
UNAUDITED CONDENSED BALANCE SHEET (Parenthetical) - $ / shares
Oct. 06, 2020
Nov. 12, 2020
Oct. 05, 2020
Sep. 30, 2020
Preferred stock, par value       $ 0.0001
Preferred stock, shares authorized       1,000,000
Preferred stock, shares issued       0
Preferred stock, shares outstanding       0
Subsequent event        
Maximum shares subject to forfeiture   1,071,823    
Class A        
Common stock, par value       $ 0.0001
Common stock, shares authorized       400,000,000
Common stock, shares issued       0
Common stock, shares outstanding       0
Class B        
Common stock, par value       $ 0.0001
Common stock, shares authorized       40,000,000
Common stock, shares issued       11,500,000
Common stock, shares outstanding       11,500,000
Class B | Subsequent event        
Maximum shares subject to forfeiture   1,285,637    
Number of shares surrendered by sponsor 2,875,000      
Class B | Founder Shares        
Maximum shares subject to forfeiture       1,500,000
Class B | Founder Shares | Subsequent event        
Common stock, shares outstanding 11,500,000   14,375,000  
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
UNAUDITED CONDENSED STATEMENT OF OPERATIONS
3 Months Ended
Sep. 30, 2020
USD ($)
$ / shares
shares
UNAUDITED CONDENSED STATEMENT OF OPERATIONS  
General and administrative expenses $ 23,448
Franchise tax expense 47,173
Net loss $ (70,621)
Weighted average shares outstanding, basic and diluted | shares 10,214,363 [1],[2]
Basic and diluted net loss per share | $ / shares $ (0.01)
[1] On October 6, 2020, the Sponsor surrendered 2,875,000 shares of Class B common stock to the Company for no consideration, resulting in a decrease of the founder shares from 14,375,000 shares to 11,500,000 shares. All shares and associated amounts have been retroactively restated to reflect the share surrender (see Note 4).
[2] This number excludes an aggregate of up to 1,500,000 Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On November 12, 2020, the underwriters partially exercised the over-allotment option to purchase as additional 1,071,823 Units; thus, only 1,285,637 Class B ordinary shares remain subject to forfeiture (see Note 4).
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.20.2
UNAUDITED CONDENSED STATEMENT OF OPERATIONS (Parenthetical) - shares
Oct. 06, 2020
Nov. 12, 2020
Oct. 05, 2020
Sep. 30, 2020
Subsequent event        
Maximum shares subject to forfeiture   1,071,823    
Class B        
Common stock, shares outstanding       11,500,000
Class B | Subsequent event        
Maximum shares subject to forfeiture   1,285,637    
Number of shares surrendered by sponsor 2,875,000      
Class B | Founder Shares        
Maximum shares subject to forfeiture       1,500,000
Class B | Founder Shares | Subsequent event        
Common stock, shares outstanding 11,500,000   14,375,000  
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
UNAUDITED CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT - 3 months ended Sep. 30, 2020 - USD ($)
Common Stock
Class A
Common Stock
Class B
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at the beginning at Jul. 05, 2020 $ 0 $ 0 $ 0 $ 0 $ 0
Balance at the beginning (in shares) at Jul. 05, 2020 0 0      
Issuance of Class B common stock to Sponsor [1],[2]   $ 1,150 23,850   25,000
Issuance of Class B common stock to Sponsor (in shares) [1],[2]   11,500,000      
Net loss (unaudited)       (70,621) (70,621)
Balance at the ending at Sep. 30, 2020 $ 0 $ 1,150 $ 23,850 $ (70,621) $ (45,621)
Balance at the ending (in shares) at Sep. 30, 2020   11,500,000      
[1] On October 6, 2020, the Sponsor surrendered 2,875,000 shares of Class B common stock to the Company for no consideration, resulting in a decrease of the founder shares from 14,375,000 shares to 11,500,000 shares. All shares and associated amounts have been retroactively restated to reflect the share surrender (see Note 4).
[2] This number includes up to 1,500,000 shares of Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On November 12, 2020, the underwriters partially exercised the over-allotment option to purchase as additional 1,071,823 Units; thus, only 1,285,637 Class B ordinary shares remain subject to forfeiture (see Note 4).
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.20.2
UNAUDITED CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT (Parenthetical) - shares
Oct. 06, 2020
Nov. 12, 2020
Oct. 05, 2020
Sep. 30, 2020
Subsequent event        
Maximum shares subject to forfeiture   1,071,823    
Class B        
Common stock, shares outstanding       11,500,000
Class B | Subsequent event        
Maximum shares subject to forfeiture   1,285,637    
Number of shares surrendered by the Sponsor 2,875,000      
Class B | Founder Shares        
Maximum shares subject to forfeiture       1,500,000
Class B | Founder Shares | Subsequent event        
Common stock, shares outstanding 11,500,000   14,375,000  
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.20.2
UNAUDITED CONDENSED STATEMENT OF CASH FLOWS
3 Months Ended
Sep. 30, 2020
USD ($)
Cash Flows from Operating Activities:  
Net loss $ (70,621)
Changes in operating assets and liabilities:  
Accounts payable 17,367
Accrued expenses 6,046
Franchise tax payable 47,173
Net cash used in operating activities (35)
Cash Flows from Financing Activities:  
Proceeds from note payable to related party 200,000
Deferred offering costs paid (181,835)
Net cash provided by financing activities 18,165
Net increase in cash 18,130
Cash - end of the period 18,130
Supplemental disclosure of noncash activities:  
Offering costs paid by Sponsor in exchange for issuance of Class B common stock 9,000
Prepaid expenses paid by Sponsor in exchange for issuance of Class B common stock 16,000
Deferred offering costs included in accrued expenses 292,000
Deferred offering costs included in accounts payable $ 15,450
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.20.2
Description of Organization, Business Operations and Basis of Presentation
3 Months Ended
Sep. 30, 2020
Description of Organization, Business Operations and Basis of Presentation  
Description of Organization, Business Operations and Basis of Presentation

Note 1—Description of Organization, Business Operations and Basis of Presentation

 

Montes Archimedes Acquisition Corp. (the "Company") was incorporated in Delaware on July 6, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the "Business Combination"). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.

 

As of September 30, 2020, the Company had not commenced any operations. All activity for the period from July 6, 2020 (inception) through September 30, 2020 relates to the Company’s formation and the preparation for the initial public offering (the “Initial Public Offering”) described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.

 

The Company’s sponsor is Patient Square Capital LLC (the "Sponsor"). The registration statement for the Company’s Initial Public Offering was declared effective on October 6, 2020. On October 9, 2020, the Company consummated its Initial Public Offering of 40,000,000 units (the “Units”) at $10.00 per Unit, generating gross proceeds of $400.0 million, and incurring offering costs of approximately $22.1 million (net of reimbursement of offering costs of $520,000 from the underwriters), inclusive of $14.0 million in deferred underwriting commissions (Note 5). The underwriters exercised the over-allotment option in full and on November 12, 2020 purchased an additional 1,071,823 Units (the “Over-Allotment Units”), generating gross proceeds of approximately $10.7 million, and incurred additional offering costs of approximately $576,000 in underwriting fees (net of reimbursement of offering costs of approximately $14,000 from the underwriters and inclusive of approximately $375,000 in deferred underwriting fees) (the “Over-Allotment”). 

 

Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 10,000,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant to the Sponsor, generating proceeds of $10.0 million (Note 4). Simultaneously with the closing of the Over-allotment on November 12, 2020, the Company consummated the second closing of the Private Placement, resulting in the purchase of an aggregate of an additional 214,365 Private Placement Warrants by the Sponsor, generating gross proceeds to the Company of approximately $214,000.

 

Upon the closing of the Initial Public Offering, the Over-Allotment, and the Private Placement, approximately $410.7 million ($10.00 per Unit) of the net proceeds of the sale of the Units in the Initial Public Offering and of the Private Placement Warrants in the Private Placement were placed in a trust account ("Trust Account") located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in U.S. "government securities," within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in money market funds meeting certain conditions under Rule 2a‑7 under the Investment Company Act, which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.

 

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete an initial Business Combination with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account). However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended (the "Investment Company Act").

 

The Company will provide holders (the "Public Stockholders") of the Company’s outstanding shares of Class A common stock sold in the Initial Public Offering (the "Public Shares") with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the Trust Account (initially anticipated to be $10.00 per Public Share), calculated as of two business days prior to the initial Business Combination, including interest earned on the funds held in the trust account and not previously released to the Company to pay the Company’s taxes, net of taxes payable. The per-share amount to be distributed to Public Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). The Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination. The Company will not redeem the Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001. If a stockholder vote is not required by applicable law or stock exchange rule and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its amended and restated certificate of incorporation (the "Certificate of Incorporation"), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission ("SEC") and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by applicable law or stock exchange rule, or the Company decides to obtain stockholder approval for business or reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Stockholder may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction. If the Company seeks stockholder approval in connection with a Business Combination, the initial stockholders (as defined below) agreed to vote any Founder Shares (as defined below in Note 4) and any Public Shares held by them in favor of a Business Combination. In addition, the initial stockholders agreed to waive their redemption rights with respect to any Founder Shares and any Public Shares held by them in connection with the completion of a Business Combination.

 

The Certificate of Incorporation will provide that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a "group" (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act")), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company. The Sponsor and the Company’s officers and directors (the "initial stockholders") agreed, pursuant to a letter agreement with the Company, that they will not propose any amendment to the Certificate of Incorporation (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (B) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable) divided by the number of then outstanding Public Shares.

 

If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or October 9, 2022, (as such period may be extended pursuant to the Certificate of Incorporation, the "Combination Period"), the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of the then outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law; and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the board of directors, liquidate and dissolve, subject in each case, to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

 

The initial stockholders agreed to waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares held by them if the Company fails to complete a Business Combination within the Combination Period. However, if the initial stockholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to the deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only, or less than, $10.00. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement (a "Target"), reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to the monies held in the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the "Securities Act"). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, then the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

 

Liquidity and Capital Resources

 

As of September 30, 2020, the Company had approximately $18,000 cash and a working capital deficit of approximately $497,000.

 

Prior to September 30, 2020, the Company’s liquidity needs were satisfied through a payment of $25,000 from the Sponsor to cover certain expenses on behalf of the Company in exchange for the issuance of the Founder Shares (as defined below), the loan under the Note from the Sponsor of $200,000 (see Note 4) to the Company. Subsequent to September 30, 2020, the liquidity needs had been satisfied through the net proceeds from the consummation of the Private Placement not held in the Trust Account. The Company fully repaid the Note on October 9, 2020. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 4). To date, there were no amounts outstanding under any Working Capital Loans.

 

Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.

 

Management continues to evaluate the impact of the COVID‑19 pandemic and has concluded that the specific impact is not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis of Presentation

 

The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the period presented. Operating results for the period from May 19, 2020 (inception) through September 30, 2020 are not necessarily indicative of the results that may be expected through December 31, 2020.

 

The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 8‑K and the final prospectus filed by the Company with the SEC on October 16, 2020 and October 9, 2020, respectively.

 

Emerging Growth Company

 

The Company is an "emerging growth company," as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the "JOBS Act"), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

 

This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

XML 21 R10.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies
3 Months Ended
Sep. 30, 2020
Summary of Significant Accounting Policies  
Summary of Significant Accounting Policies

Note 2—Summary of Significant Accounting Policies

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. At September 30, 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

 

Cash and Cash Equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of September 30, 2020.

 

Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, "Fair Value Measurement" approximates the carrying amounts represented in the balance sheet.

 

Use of Estimates

 

The preparation of the financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

 

Deferred Offering Costs Associated with the Initial Public Offering

 

Deferred offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering and that were charged to stockholders’ equity upon the completion of the Initial Public Offering in October 2020.

 

Net Loss Per Common Share

 

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, "Earnings Per Share." Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period excluding common stock subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 1,500,000 shares of common stock that are subject to forfeiture if the over-allotment option is not exercised by the underwriters (Note 4). At September 30, 2020, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into shares of common stock and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented.

 

Income Taxes

 

The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, "Income Taxes." Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. Deferred tax assets were deemed immaterial as of September 30, 2020.

 

FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2020. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of September 30, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

 

Recent Accounting Standards

 

The Company’s management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying financial statements.

XML 22 R11.htm IDEA: XBRL DOCUMENT v3.20.2
Initial Public Offering
3 Months Ended
Sep. 30, 2020
Initial Public Offering  
Initial Public Offering

Note 3—Initial Public Offering

 

On October 9, 2020, the Company consummated its Initial Public Offering of 40,000,000 Units at $10.00 per Unit, generating gross proceeds of $400.0 million, and incurring offering costs of approximately $22.1 million (net of reimbursement of offering costs of $520,000 from the underwriters), inclusive of $14.0 million in deferred underwriting commissions. The Underwriters exercised the over-allotment option in full and on November 12, 2020 purchased an additional 1,071,823 Over-Allotment Units, generating gross proceeds of approximately $10.7 million, and incurred additional offering costs of approximately $576,000 in underwriting fees (net of reimbursement of offering costs of approximately $14,000 from the underwriters and inclusive of approximately $375,000 in deferred underwriting fees). 

 

Each Unit consists of one share of Class A common stock, and one-half of one redeemable warrant (each, a "Public Warrant"). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 6).

XML 23 R12.htm IDEA: XBRL DOCUMENT v3.20.2
Related Party Transactions
3 Months Ended
Sep. 30, 2020
Related Party Transactions  
Related Party Transactions

Note 4—Related Party Transactions

 

Founder Shares

 

On July 23, 2020, an affiliate of the Sponsor paid an aggregate of $25,000 for certain expenses on behalf of the Company in exchange for issuance of 14,375,000 shares of the Company’s Class B common stock, par value $0.0001 per share (the "Founder Shares"), with such shares subsequently transferred to the Sponsor. On October 6, 2020, the Sponsor surrendered 2,875,000 shares of Class B common stock to the Company for no consideration, resulting in a decrease of the Founder Shares from 14,375,000 shares to 11,500,000 shares. All shares and associated amounts have been retroactively restated to reflect the share surrender. The initial stockholders agreed to forfeit up to 1,500,000 Founder Shares to the extent that the over-allotment option is not exercised in full by the underwriters, so that the Founder Shares will represent 20.0% of the Company’s issued and outstanding shares of common stock after the Initial Public Offering. The underwriters exercised their over-allotment option on November 12, 2020; thus, only 1,285,637 shares of Class B common stock remain subject to forfeiture.

 

The Initial Stockholders agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination or (B) subsequent to the initial Business Combination, (x) if the last reported sale price of Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30‑trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the stockholders having the right to exchange their common stock for cash, securities or other property.

 

Private Placement Warrants

 

Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 10,000,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant to the Sponsor, generating proceeds of $10.0 million. Simultaneously with the closing of the Over-allotment on November 12, 2020, the Company consummated the second closing of the Private Placement, resulting in the purchase of an aggregate of an additional 214,365 Private Placement Warrants by the Sponsor, generating gross proceeds to the Company of approximately $214,000.

 

Each whole Private Placement Warrant is exercisable for one whole share of Class A common stock at a price of $11.50 per share, subject to adjustment. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable for cash (except as described below) and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees.

 

The Sponsor agreed, subject to limited exceptions, not to transfer, assign or sell the Private Placement Warrants until 30 days after the completion of the initial Business Combination.

 

Related Party Loans

 

On July 23, 2020, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the "Note"). This loan was non-interest bearing and payable upon the completion of the Initial Public Offering. As of September 30, 2020, the Company borrowed $200,000 under the Note. The Note was fully repaid on October 9, 2020.

 

In addition, in order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required ("Working Capital Loans"). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans could be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. To date, the Company had no borrowings under the Working Capital Loans.

 

Administrative Services Agreement

 

The Company entered into an agreement that will provide that, commencing on October 7, 2020 through the earlier of consummation of the initial Business Combination and the liquidation, the Company will pay an affiliate of the Sponsor $10,000 per month for office space and administrative support services.

XML 24 R13.htm IDEA: XBRL DOCUMENT v3.20.2
Commitments & Contingencies
3 Months Ended
Sep. 30, 2020
Commitments & Contingencies.  
Commitments & Contingencies

Note 5—Commitments & Contingencies

 

Registration Rights

 

The holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) are entitled to registration rights pursuant to the registration rights agreement. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain "piggy-back" registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Underwriting Agreement

 

The underwriters were entitled to an underwriting discount of $0.20 per unit, or $8.0 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or $14.0 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. The underwriters agreed to make a payment to the Company in an amount of 0.13% of the gross proceeds of the Initial Public Offering, or $520,000, to reimburse certain of offering expenses. The Company received such reimbursement on October 27, 2020.

 

Upon closing of the Over-allotment on November 12, 2020, the underwriters received approximately $214,000 in fees paid upfront and eligible for an additional deferred underwriting commissions of approximately $375,000. In addition, the underwriters agreed to make an addition payment to the Company in an amount of 0.13% of the gross proceeds of the Over-allotment, or approximately $14,000, to reimburse certain of offering expenses.

XML 25 R14.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity
3 Months Ended
Sep. 30, 2020
Stockholders' Equity  
Stockholders' Equity

Note 6—Stockholders’ Equity

 

Class A Common Stock—The Company is authorized to issue 400,000,000 shares of Class A common stock with a par value of $0.0001 per share. As of September 30, 2020, there were no shares of Class A common stock issued or outstanding.

 

Class B Common Stock—The Company is authorized to issue 40,000,000 shares of Class B common stock with a par value of $0.0001 per share. On July 23, 2020, an affiliate of the Sponsor paid an aggregate of $25,000 for certain expenses on behalf of the Company in exchange for issuance of 14,375,000 shares of Class B common stock, with such shares subsequently transferred to the Sponsor. On October 6, 2020, the Sponsor surrendered 2,875,000 shares of Class B common stock to the Company for no consideration, resulting in a decrease of the outstanding Class B common stock from 14,375,000 shares to 11,500,000 shares. All shares and associated amounts have been retroactively restated to reflect the share surrender. Of these, an aggregate of up to 1,500,000 shares of Class B common stock that are subject to forfeiture to the Company by the initial stockholders for no consideration to the extent that the underwriters’ over-allotment option is not exercised in full or in part, so that the number of Founder Shares will equal 20% of the Company’s issued and outstanding shares of common stock after the Initial Public Offering. The underwriters exercised their over-allotment option on November 12, 2020; thus, only 1,285,637 shares of Class B common stock remain subject to forfeiture.

 

Stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. Holders of our Class A common stock and holders of our Class B common stock will vote together as a single class on all matters submitted to a vote of our stockholders except as required by law.

 

The Class B common stock will automatically convert into Class A common stock on the first business day following the completion of the initial Business Combination at a ratio such that the number of shares of Class A common stock issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of (i) the total number of shares of Class A common stock issued and outstanding upon completion of the Initial Public Offering, plus (ii) the sum of (a) the total number of shares of Class A common stock issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the completion of the initial Business Combination, excluding any shares of Class A common stock or equity-linked securities exercisable for or convertible into shares of Class A common stock issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor upon conversion of Working Capital Loans, minus (b) the number of Public Shares redeemed by Public Stockholders in connection with the initial Business Combination. In no event will the shares of Class B common stock convert into shares of Class A common stock at a rate of less than one to one.

 

Preferred Stock—The Company is authorized to issue 1,000,000 shares of preferred stock, par value $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of September 30, 2020, there were no shares of preferred stock issued or outstanding.

 

Warrants—Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or holders are permitted to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement as a result of (i) the Company’s failure to have an effective registration statement by the 60th business day after the closing of the initial Business Combination or (ii) a notice of redemption described below under "Redemption of warrants when the price per Class A common stock equals or exceeds $10.00"). If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

 

The Company is not registering the shares of Class A common stock issuable upon exercise of the warrants at this time. However, the Company has agreed that as soon as practicable, but in no event later than twenty business days after the closing of the initial Business Combination, the Company will use its commercially reasonable efforts to file with the SEC and have an effective registration statement covering the shares of Class A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed. If a registration statement covering the Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a "cashless basis" in accordance with Section 3(a)(9) of the Securities Act or another exemption.

 

The warrants will have an exercise price of $11.50 per share and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. If (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company and, (i) in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance, and (ii) to the extent that such issuance is made to the Sponsor or its affiliates, without taking into account the transfer of Founder Shares or Private Placement Warrants (including if such transfer is effectuated as a surrender to the Company and subsequent reissuance by the Company) by the Sponsor in connection with such issuance) (the "Newly Issued Price"), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the completion of the initial Business Combination (net of redemptions), and (z) the volume-weighted average trading price of Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company completes its initial Business Combination (such price, the "Market Value") is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices described under "Redemption of warrants when the price per Class A common stock equals or exceeds $18.00" and "Redemption of warrants when the price per Class A common stock equals or exceeds $10.00" will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively.

 

The Private Placement Warrants will be identical to the Public Warrants, except that the Private Placement Warrants (including the Class A common stock issuable upon exercise of the Private Placement Warrants) will not be transferable, assignable or salable until 30 days after the completion of the initial Business Combination and they will not be redeemable by the Company so long as they are held by the Sponsor or its permitted transferees.

 

Redemption of warrants when the price per share of our Class A common stock equals or exceeds $18.00:

 

Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):

 

in whole and not in part;

 

at a price of $0.01 per warrant;

 

upon a minimum of 30 days’ prior written notice of redemption; and

 

if, and only if, the last reported sale price of Class A common stock for any 20 trading days within a 30‑trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders (the "Reference Value") equals or exceeds $18.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like).

 

However, in this case, the Company will not redeem the warrants unless an effective registration statement under the Securities Act covering the Class A common stock issuable upon exercise of the warrants is effective and a current prospectus relating to those shares of Class A common stock is available throughout the 30‑day redemption period. Any such exercise would not be on a "cashless" basis and would require the exercising warrant holder to pay the exercise price for each warrant being exercised.

 

Redemption of warrants when the price per share of our Class A common stock equals or exceeds $10.00

 

Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):

 

in whole and not in part;

 

at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption, provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the "fair market value" of Class A common stock;

 

if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted for stock splits, stock dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like); and

 

if the Reference Value is less than $18.00 per share (as adjusted for stock splits, stock dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like), the Private Placement Warrants must also concurrently be called for redemption on the same terms (except as described herein with respect to a holder’s ability to cashless exercise its warrants) as the outstanding Public Warrants, as described above.

 

The "fair market value" of Class A common stock shall mean the volume-weighted average price of Class A common stock for the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 shares of Class A common stock per warrant (subject to adjustment).

 

In no event will the Company be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

XML 26 R15.htm IDEA: XBRL DOCUMENT v3.20.2
Subsequent Events
3 Months Ended
Sep. 30, 2020
Subsequent Events  
Subsequent Events

Note 7—Subsequent Events

 

The Company received the reimbursement of $520,000 from the underwriters for certain of offering expenses on October 27, 2020.

 

The Company evaluated subsequent events and transactions that occurred up to the date unaudited condensed financial statements were available to be issued. Based upon this review, the Company determined that, except as disclosed above and in Note 3 and 4, there have been no events that have occurred that would require adjustments to the disclosures in the unaudited condensed financial statements.

 

Management has evaluated subsequent events and transactions that occurred after the balance sheet date through the date the balance sheet was available for issuance. Based upon this review, except as noted above, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

XML 27 R16.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Sep. 30, 2020
Summary of Significant Accounting Policies  
Basis of Presentation

Basis of Presentation

 

The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the period presented. Operating results for the period from May 19, 2020 (inception) through September 30, 2020 are not necessarily indicative of the results that may be expected through December 31, 2020.

 

The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 8‑K and the final prospectus filed by the Company with the SEC on October 16, 2020 and October 9, 2020, respectively.

Emerging Growth Company

Emerging Growth Company

 

The Company is an "emerging growth company," as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the "JOBS Act"), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

 

This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Concentration of Credit Risk

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. At September 30, 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

Cash and Cash Equivalents

Cash and Cash Equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of September 30, 2020.

Financial Instruments

Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, "Fair Value Measurement" approximates the carrying amounts represented in the balance sheet.

Use of Estimates

Use of Estimates

 

The preparation of the financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

Deferred Offering Costs Associated with the Initial Public Offering

Deferred Offering Costs Associated with the Initial Public Offering

 

Deferred offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering and that were charged to stockholders’ equity upon the completion of the Initial Public Offering in October 2020.

Net Loss per Common Share

Net Loss Per Common Share

 

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, "Earnings Per Share." Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period excluding common stock subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 1,500,000 shares of common stock that are subject to forfeiture if the over-allotment option is not exercised by the underwriters (Note 4). At September 30, 2020, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into shares of common stock and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented.

Income Taxes

Income Taxes

 

The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, "Income Taxes." Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. Deferred tax assets were deemed immaterial as of September 30, 2020.

 

FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2020. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of September 30, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

Recent Accounting Standards

Recent Accounting Standards

 

The Company’s management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying financial statements.

XML 28 R17.htm IDEA: XBRL DOCUMENT v3.20.2
Description of Organization, Business Operations and Basis of Presentation (Details) - USD ($)
3 Months Ended
Nov. 12, 2020
Oct. 27, 2020
Oct. 09, 2020
Jul. 23, 2020
Sep. 30, 2020
Description of Organization, Business Operations and Basis of Presentation          
Revenues         $ 0
Offering cost         $ 181,835
Threshold business days prior to Initial Business Combination for redemption of public shares         2 days
Threshold period from closing of public offering the company is obligated to complete business combination         24 months
Threshold trading days to redeem the shares         10 days
Cash         $ 18,130
Working capital deficit         497,000
Subsequent event          
Description of Organization, Business Operations and Basis of Presentation          
Gross proceeds $ 10,700,000        
Proceeds from IPO and Private Placement placed in a Trust Account     $ 410,700,000    
Proceeds per unit from IPO and Private Placement placed in a Trust Account     $ 10.00    
Offering cost 576,000        
Deferred underwriting commissions $ 375,000        
Maximum shares subject to forfeiture 1,071,823        
Reimbursement of offering costs from the underwriter $ 14,000 $ 520,000      
Related Party Loans | Working Capital Loans          
Description of Organization, Business Operations and Basis of Presentation          
Loan amount outstanding         0
Founder Shares          
Description of Organization, Business Operations and Basis of Presentation          
Proceeds received from related party to cover certain expense payments in exchange for shares issued       $ 25,000  
Sponsor | Related Party Loans | Promissory Note          
Description of Organization, Business Operations and Basis of Presentation          
Loan amount outstanding         $ 200,000
IPO          
Description of Organization, Business Operations and Basis of Presentation          
Percentage of aggregate fair market value of assets         80.00%
Ownership interest to be acquired on post-transaction company         50.00%
Minimum net tangible assets upon consummation of business combination         $ 5,000,001
Maximum percentage of shares that can be redeemed without prior consent of the Company         15.00%
Percentage of shares of stock the Company is obligated to redeem without consummating a business combination         100.00%
Per share value of residual assets in trust account         $ 10.00
Interest to pay dissolution expenses         $ 100,000
IPO | Subsequent event          
Description of Organization, Business Operations and Basis of Presentation          
Number of units issued     40,000,000    
Price per share     $ 10.00    
Gross proceeds     $ 400,000,000    
Offering cost     22,100,000    
Deferred underwriting commissions     14,000,000    
Reimbursement of offering costs from the underwriter     $ 520,000    
Private Placement | Sponsor | Subsequent event          
Description of Organization, Business Operations and Basis of Presentation          
Price per share     $ 1.00    
Gross proceeds $ 214,000   $ 10,000,000    
Number of warrants issued 214,365   10,000,000    
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies (Details)
3 Months Ended
Sep. 30, 2020
USD ($)
shares
Summary of Significant Accounting Policies  
Concentrations of credit risk, financial instruments $ 250,000
Cash equivalents $ 0
Number of anti-dilutive shares subject to forfeiture excluded from weighted-average shares calculation | shares 1,500,000
Unrecognized tax benefits $ 0
Amounts accrued for the payment of interest and penalties $ 0
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.20.2
Initial Public Offering (Details) - USD ($)
3 Months Ended
Nov. 12, 2020
Oct. 27, 2020
Oct. 09, 2020
Sep. 30, 2020
Initial Public Offering        
Offering cost       $ 181,835
Subsequent event        
Initial Public Offering        
Gross proceeds $ 10,700,000      
Offering cost 576,000      
Reimbursement of offering costs from the underwriter $ 14,000 $ 520,000    
Maximum shares subject to forfeiture 1,071,823      
Deferred underwriting commissions $ 375,000      
IPO | Subsequent event        
Initial Public Offering        
Number of units issued     40,000,000  
Price per share     $ 10.00  
Gross proceeds     $ 400,000,000  
Offering cost     22,100,000  
Reimbursement of offering costs from the underwriter     520,000  
Deferred underwriting commissions     $ 14,000,000  
Exercise price of warrants (in dollars per share)     $ 11.50  
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.20.2
Related Party Transactions - Founder Shares (Details) - USD ($)
Oct. 06, 2020
Jul. 23, 2020
Nov. 12, 2020
Oct. 05, 2020
Sep. 30, 2020
Subsequent event          
Related Party Transactions          
Maximum shares subject to forfeiture     1,071,823    
Founder Shares          
Related Party Transactions          
Proceeds received from related party to cover certain expense payments in exchange for shares issued   $ 25,000      
Founder Shares | Subsequent event          
Related Party Transactions          
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) $ 12.00        
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences 20 days        
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination 150 days        
Founder Shares | Maximum | Subsequent event          
Related Party Transactions          
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences 30 days        
Class B          
Related Party Transactions          
Common stock, par value         $ 0.0001
Shares outstanding         11,500,000
Class B | Subsequent event          
Related Party Transactions          
Number of shares surrendered by the Sponsor 2,875,000        
Maximum shares subject to forfeiture     1,285,637    
Class B | Founder Shares          
Related Party Transactions          
Maximum shares subject to forfeiture         1,500,000
Common stock, shares subject to forfeiture, as a percent of issued and outstanding shares (as a percent)         20.00%
Class B | Founder Shares | Subsequent event          
Related Party Transactions          
Shares outstanding 11,500,000     14,375,000  
Class B | Founder Shares | Affiliate of Sponsor          
Related Party Transactions          
Number of shares issued   14,375,000      
Common stock, par value   $ 0.0001      
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.20.2
Related Party Transactions - Private Placement Warrants (Details) - Subsequent event - USD ($)
Nov. 12, 2020
Oct. 09, 2020
Related Party Transactions    
Gross proceeds $ 10,700,000  
Private Placement | Sponsor    
Related Party Transactions    
Number of warrants to purchase the shares issued (in shares) 214,365 10,000,000
Price of warrants (in dollars per share)   $ 1.00
Proceeds from Issuance of Warrants   $ 10,000,000
Gross proceeds $ 214,000 $ 10,000,000
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination   30 days
Private Placement | Class A    
Related Party Transactions    
Exercise price of warrants (in dollars per share)   $ 11.50
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.20.2
Related Party Transactions - Related Party Loans and Administrative Services Agreement (Details) - USD ($)
Sep. 30, 2020
Jul. 23, 2020
Related Party Loans | Working Capital Loans    
Related Party Transactions    
Loan amount outstanding $ 0  
Maximum loans convertible into warrants   $ 1,500,000
Conversion price per warrant   $ 1.00
Related Party Loans | Sponsor | Promissory Note    
Related Party Transactions    
Maximum borrowing capacity of related party promissory note   $ 300,000
Loan amount outstanding 200,000  
Administrative Services Agreement | Affiliate of Sponsor    
Related Party Transactions    
Monthly office space and administrative support expenses $ 10,000  
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.20.2
Commitments and Contingencies (Details)
3 Months Ended
Nov. 12, 2020
USD ($)
Sep. 30, 2020
USD ($)
item
$ / shares
Commitments & Contingencies    
Maximum number of demands for registration of securities | item   3
Cash underwriting discount per unit | $ / shares   $ 0.20
Cash underwriting discount   $ 8,000,000
Deferred underwriting commissions per unit | $ / shares   $ 0.35
Deferred underwriting commissions   $ 14,000,000
Reimbursement of offering costs receivable from the underwriter (as a percent)   0.13%
Reimbursement of offering costs receivable from the underwriter   $ 520,000
Subsequent event    
Commitments & Contingencies    
Deferred underwriting commissions $ 375,000  
Reimbursement of offering costs receivable from the underwriter (as a percent) 0.13%  
Reimbursement of offering costs receivable from the underwriter $ 14,000  
Underwriter fees payable $ 214,000  
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity - Common Stock (Details)
3 Months Ended
Oct. 06, 2020
shares
Jul. 23, 2020
USD ($)
Sep. 30, 2020
Vote
$ / shares
shares
Nov. 12, 2020
shares
Oct. 05, 2020
shares
Stockholders' Equity          
Common stock, number of votes per share | Vote     1    
Subsequent event          
Stockholders' Equity          
Maximum shares subject to forfeiture       1,071,823  
Founder Shares          
Stockholders' Equity          
Proceeds received from related party to cover certain expense payments in exchange for shares issued | $   $ 25,000      
Class A          
Stockholders' Equity          
Common stock, shares authorized     400,000,000    
Common stock, par value | $ / shares     $ 0.0001    
Common stock, shares issued     0    
Common stock, shares outstanding     0    
Class B          
Stockholders' Equity          
Common stock, shares authorized     40,000,000    
Common stock, par value | $ / shares     $ 0.0001    
Common stock, shares issued     11,500,000    
Common stock, shares outstanding     11,500,000    
Number of common stock issuable pursuant to Initial Business Combination, as a percent of outstanding shares (in shares)     20.00%    
Class B | Subsequent event          
Stockholders' Equity          
Number of shares surrendered by sponsor 2,875,000        
Maximum shares subject to forfeiture       1,285,637  
Class B | Founder Shares          
Stockholders' Equity          
Maximum shares subject to forfeiture     1,500,000    
Common stock, shares subject to forfeiture, as a percent of issued and outstanding shares (as a percent)     20.00%    
Class B | Founder Shares | Subsequent event          
Stockholders' Equity          
Common stock, shares outstanding 11,500,000       14,375,000
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity - Preferred Stock (Details)
Sep. 30, 2020
$ / shares
shares
Stockholders' Equity  
Preferred stock, shares authorized 1,000,000
Preferred stock, par value | $ / shares $ 0.0001
Preferred stock, shares issued 0
Preferred stock, shares outstanding 0
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity - Warrants (Details)
3 Months Ended
Sep. 30, 2020
$ / shares
shares
Stockholders' Equity  
Threshold trading days for calculating volume-weighted average price 10 days
Class A  
Stockholders' Equity  
Threshold minimum percentage of gross proceeds on total equity proceeds (as a percent) 60.00%
Redemption of Warrants when price per share of Class A common stock equals or exceeds $10.00  
Stockholders' Equity  
Newly Issued Price (in dollars per share) $ 10.00
Redemption of Warrants when price per share of Class A common stock is less than $18.00 | Class A  
Stockholders' Equity  
Threshold consecutive trading days for redemption of warrants 20 days
Closing of Initial Business Combination  
Stockholders' Equity  
Newly Issued Price (in dollars per share) $ 9.20
Adjustment of exercise price of warrants based on market value and newly issued price (as a percent) 115.00%
Closing of Initial Business Combination | Maximum  
Stockholders' Equity  
Newly Issued Price (in dollars per share) $ 18.00
Closing of Initial Business Combination | Class A  
Stockholders' Equity  
Newly Issued Price (in dollars per share) 9.20
Public Warrants  
Stockholders' Equity  
Exercise price of warrants (in dollars per share) $ 11.50
Warrants exercisable term after the completion of a business combination 30 days
Warrants exercisable term from the closing of the public offering 12 months
Threshold maximum period for registration statement to become effective after business combination 60 days
Maximum redemption feature per warrant | shares 0.361
Public Warrants | Class A  
Stockholders' Equity  
Exercise price of warrants (in dollars per share) $ 10.00
Public Warrants | Redemption of Warrants when price per share of Class A common stock equals or exceeds $18.00  
Stockholders' Equity  
Redemption price per warrant (in dollars per share) $ 0.10
Minimum threshold written notice period for redemption of public warrants 30 days
Stock price trigger for redemption of warrants (in dollars per share) $ 10.00
Adjustment of exercise price of warrants based on market value and newly issued price (as a percent) 100.00%
Public Warrants | Redemption of Warrants when price per share of Class A common stock equals or exceeds $18.00 | Maximum  
Stockholders' Equity  
Adjustment of exercise price of warrants based on market value and newly issued price (as a percent) 180.00%
Private Placement Warrants  
Stockholders' Equity  
Threshold trading days for redemption of warrants 30 days
Private Placement Warrants | Redemption of Warrants when price per share of Class A common stock equals or exceeds $18.00  
Stockholders' Equity  
Redemption price per warrant (in dollars per share) $ 0.01
Minimum threshold written notice period for redemption of public warrants 30 days
Stock price trigger for redemption of warrants (in dollars per share) $ 18.00
Threshold trading days for redemption of warrants 20 days
Private Placement Warrants | Closing of Initial Business Combination  
Stockholders' Equity  
Newly Issued Price (in dollars per share) $ 18.00
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.20.2
Subsequent Events (Details) - USD ($)
Nov. 12, 2020
Oct. 27, 2020
Subsequent event    
Subsequent Events    
Reimbursement of offering costs from the underwriter $ 14,000 $ 520,000
EXCEL 39 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 41 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 42 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 63 225 1 true 24 0 false 6 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.maacu.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - UNAUDITED CONDENSED BALANCE SHEET Sheet http://www.maacu.com/role/StatementUnauditedCondensedBalanceSheet UNAUDITED CONDENSED BALANCE SHEET Statements 2 false false R3.htm 00105 - Statement - UNAUDITED CONDENSED BALANCE SHEET (Parenthetical) Sheet http://www.maacu.com/role/StatementUnauditedCondensedBalanceSheetParenthetical UNAUDITED CONDENSED BALANCE SHEET (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - UNAUDITED CONDENSED STATEMENT OF OPERATIONS Sheet http://www.maacu.com/role/StatementUnauditedCondensedStatementOfOperations UNAUDITED CONDENSED STATEMENT OF OPERATIONS Statements 4 false false R5.htm 00205 - Statement - UNAUDITED CONDENSED STATEMENT OF OPERATIONS (Parenthetical) Sheet http://www.maacu.com/role/StatementUnauditedCondensedStatementOfOperationsParenthetical UNAUDITED CONDENSED STATEMENT OF OPERATIONS (Parenthetical) Statements 5 false false R6.htm 00300 - Statement - UNAUDITED CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT Sheet http://www.maacu.com/role/StatementUnauditedCondensedStatementOfChangesInStockholdersDeficit UNAUDITED CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT Statements 6 false false R7.htm 00305 - Statement - UNAUDITED CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT (Parenthetical) Sheet http://www.maacu.com/role/StatementUnauditedCondensedStatementOfChangesInStockholdersDeficitParenthetical UNAUDITED CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT (Parenthetical) Statements 7 false false R8.htm 00400 - Statement - UNAUDITED CONDENSED STATEMENT OF CASH FLOWS Sheet http://www.maacu.com/role/StatementUnauditedCondensedStatementOfCashFlows UNAUDITED CONDENSED STATEMENT OF CASH FLOWS Statements 8 false false R9.htm 10101 - Disclosure - Description of Organization, Business Operations and Basis of Presentation Sheet http://www.maacu.com/role/DisclosureDescriptionOfOrganizationBusinessOperationsAndBasisOfPresentation Description of Organization, Business Operations and Basis of Presentation Notes 9 false false R10.htm 10201 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.maacu.com/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 10 false false R11.htm 10301 - Disclosure - Initial Public Offering Sheet http://www.maacu.com/role/DisclosureInitialPublicOffering Initial Public Offering Notes 11 false false R12.htm 10401 - Disclosure - Related Party Transactions Sheet http://www.maacu.com/role/DisclosureRelatedPartyTransactions Related Party Transactions Notes 12 false false R13.htm 10501 - Disclosure - Commitments & Contingencies Sheet http://www.maacu.com/role/DisclosureCommitmentsContingencies Commitments & Contingencies Notes 13 false false R14.htm 10601 - Disclosure - Stockholders' Equity Sheet http://www.maacu.com/role/DisclosureStockholdersEquity Stockholders' Equity Notes 14 false false R15.htm 10701 - Disclosure - Subsequent Events Sheet http://www.maacu.com/role/DisclosureSubsequentEvents Subsequent Events Notes 15 false false R16.htm 20202 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.maacu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.maacu.com/role/DisclosureSummaryOfSignificantAccountingPolicies 16 false false R17.htm 40101 - Disclosure - Description of Organization, Business Operations and Basis of Presentation (Details) Sheet http://www.maacu.com/role/DisclosureDescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationDetails Description of Organization, Business Operations and Basis of Presentation (Details) Details http://www.maacu.com/role/DisclosureDescriptionOfOrganizationBusinessOperationsAndBasisOfPresentation 17 false false R18.htm 40201 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.maacu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://www.maacu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies 18 false false R19.htm 40301 - Disclosure - Initial Public Offering (Details) Sheet http://www.maacu.com/role/DisclosureInitialPublicOfferingDetails Initial Public Offering (Details) Details http://www.maacu.com/role/DisclosureInitialPublicOffering 19 false false R20.htm 40401 - Disclosure - Related Party Transactions - Founder Shares (Details) Sheet http://www.maacu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails Related Party Transactions - Founder Shares (Details) Details 20 false false R21.htm 40402 - Disclosure - Related Party Transactions - Private Placement Warrants (Details) Sheet http://www.maacu.com/role/DisclosureRelatedPartyTransactionsPrivatePlacementWarrantsDetails Related Party Transactions - Private Placement Warrants (Details) Details 21 false false R22.htm 40403 - Disclosure - Related Party Transactions - Related Party Loans and Administrative Services Agreement (Details) Sheet http://www.maacu.com/role/DisclosureRelatedPartyTransactionsRelatedPartyLoansAndAdministrativeServicesAgreementDetails Related Party Transactions - Related Party Loans and Administrative Services Agreement (Details) Details 22 false false R23.htm 40501 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.maacu.com/role/DisclosureCommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Details 23 false false R24.htm 40601 - Disclosure - Stockholders' Equity - Common Stock (Details) Sheet http://www.maacu.com/role/DisclosureStockholdersEquityCommonStockDetails Stockholders' Equity - Common Stock (Details) Details 24 false false R25.htm 40602 - Disclosure - Stockholders' Equity - Preferred Stock (Details) Sheet http://www.maacu.com/role/DisclosureStockholdersEquityPreferredStockDetails Stockholders' Equity - Preferred Stock (Details) Details 25 false false R26.htm 40603 - Disclosure - Stockholders' Equity - Warrants (Details) Sheet http://www.maacu.com/role/DisclosureStockholdersEquityWarrantsDetails Stockholders' Equity - Warrants (Details) Details 26 false false R27.htm 40701 - Disclosure - Subsequent Events (Details) Sheet http://www.maacu.com/role/DisclosureSubsequentEventsDetails Subsequent Events (Details) Details http://www.maacu.com/role/DisclosureSubsequentEvents 27 false false All Reports Book All Reports maacu-20200930.xml maacu-20200930.xsd maacu-20200930_cal.xml maacu-20200930_def.xml maacu-20200930_lab.xml maacu-20200930_pre.xml http://xbrl.sec.gov/dei/2020-01-31 http://fasb.org/us-gaap/2020-01-31 http://fasb.org/srt/2020-01-31 true true ZIP 44 0001104659-20-127404-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-20-127404-xbrl.zip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